candidate_genes,disease,celltype,y,user_question,full_query
"['RPS26', 'AFF4', 'TMEM97', 'DNAJC6', 'ZNF208']",type 1 diabetes mellitus,pancreatic epsilon cell,RPS26,"Among the genes RPS26, AFF4, TMEM97, DNAJC6, and ZNF208, which one shows the highest cell-type specificity in pancreatic epsilon cells in relation to type 1 diabetes mellitus?","Among the genes RPS26, AFF4, TMEM97, DNAJC6, and ZNF208, which one shows the highest cell-type specificity in pancreatic epsilon cells in relation to type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the pancreatic epsilon cell-activated genes in PINNACLE; this subset represents the cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INS', 'RAB3B', 'CSRNP3', 'ZNF326', 'DUSP28']",type 1 diabetes mellitus,pancreatic epsilon cell,INS,"Which gene among INS, RAB3B, CSRNP3, ZNF326, and DUSP28 exhibits the highest specificity in pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among INS, RAB3B, CSRNP3, ZNF326, and DUSP28 exhibits the highest specificity in pancreatic epsilon cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Using the PINNACLE platform, identify all verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['EBLN2', 'SPAG16-DT', 'HSPA12B', 'EMD', 'COMMD6']",type 1 diabetes mellitus,pancreatic epsilon cell,COMMD6,"Which gene among EBLN2, SPAG16-DT, HSPA12B, EMD, and COMMD6 exhibits the greatest cell-type specific expression in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among EBLN2, SPAG16-DT, HSPA12B, EMD, and COMMD6 exhibits the greatest cell-type specific expression in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which pancreatic epsilon cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a notably higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale outlining its biological relevance."
"['NDUFA11', 'CDKN2C', 'PRIMPOL', 'COL12A1', 'LINC02478']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA11,"Among NDUFA11, CDKN2C, PRIMPOL, COL12A1, and LINC02478, which gene exhibits the highest cell-type specificity in pancreatic epsilon cells, thereby representing the most promising target for type 1 diabetes mellitus?","Among NDUFA11, CDKN2C, PRIMPOL, COL12A1, and LINC02478, which gene exhibits the highest cell-type specificity in pancreatic epsilon cells, thereby representing the most promising target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the pancreatic epsilon cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for the disease. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TVP23A', 'FGF18', 'NDUFA1', 'IFTAP', 'ACOT9']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA1,"Which gene among TVP23A, FGF18, NDUFA1, IFTAP, and ACOT9 exhibits the highest specificity for pancreatic epsilon cells, making it the most promising target for type 1 diabetes mellitus?","Which gene among TVP23A, FGF18, NDUFA1, IFTAP, and ACOT9 exhibits the highest specificity for pancreatic epsilon cells, making it the most promising target for type 1 diabetes mellitus? Identify all verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic epsilon cell-activated genes overlap with these targets, and compute the average embedding of this overlapping set as a reference. Then, calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['IFIT5', 'TMEM258', 'HHATL-AS1', 'SLC46A2', 'OR1A1']",type 1 diabetes mellitus,pancreatic epsilon cell,TMEM258,"Which gene, among IFIT5, TMEM258, HHATL-AS1, SLC46A2, and OR1A1, exhibits the highest cell-type specificity in pancreatic epsilon cells as a potential candidate for targeted investigations in type 1 diabetes mellitus?","Which gene, among IFIT5, TMEM258, HHATL-AS1, SLC46A2, and OR1A1, exhibits the highest cell-type specificity in pancreatic epsilon cells as a potential candidate for targeted investigations in type 1 diabetes mellitus? Retrieve the validated therapeutic targets for type 1 diabetes mellitus along with their cell-type–specific embeddings from PINNACLE. Identify the subset of these targets that overlaps with the pancreatic epsilon cell-activated genes in PINNACLE to define the cell-type–specific targets for this condition. Calculate the average embedding for these overlapping targets, then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a distinctly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['OXNAD1', 'NDUFA3', 'ADGRA2', 'ADAT1', 'ZNF517']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA3,"Among the following genes—OXNAD1, NDUFA3, ADGRA2, ADAT1, and ZNF517—which one exhibits the highest cell-type specificity in pancreatic epsilon cells and represents the most promising candidate for therapeutic targeting in type 1 diabetes mellitus?","Among the following genes—OXNAD1, NDUFA3, ADGRA2, ADAT1, and ZNF517—which one exhibits the highest cell-type specificity in pancreatic epsilon cells and represents the most promising candidate for therapeutic targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic epsilon-cell activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00707', 'NDUFS7', 'PART1', 'ASB4', 'DPY30']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFS7,"Which gene among LINC00707, NDUFS7, PART1, ASB4, and DPY30 exhibits the highest cell-type specificity in pancreatic epsilon cells relevant to type 1 diabetes mellitus research?","Which gene among LINC00707, NDUFS7, PART1, ASB4, and DPY30 exhibits the highest cell-type specificity in pancreatic epsilon cells relevant to type 1 diabetes mellitus research? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Then, from the pancreatic epsilon cell–activated genes in PINNACLE, determine which genes overlap with these therapeutic targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average embedding and each individual gene's embedding. If one gene shows a significantly higher similarity than all others, nominate it as the top candidate for therapeutic targeting and provide a concise, evidence-based rationale for its biological relevance."
"['PFN4', 'MYH8', 'RITA1', 'EPS15L1', 'NDUFB2']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB2,"Which gene among PFN4, MYH8, RITA1, EPS15L1, and NDUFB2 exhibits the highest cell-type specificity in pancreatic epsilon cells for a potential role in targeting type 1 diabetes mellitus?","Which gene among PFN4, MYH8, RITA1, EPS15L1, and NDUFB2 exhibits the highest cell-type specificity in pancreatic epsilon cells for a potential role in targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells in PINNACLE, defining this intersection as the cell-type–specific targets. Compute the average embedding of these targets, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC25A32', 'SCGB1D2', 'MT-ND1', 'OCIAD1', 'ACVR2B-AS1']",type 1 diabetes mellitus,pancreatic epsilon cell,MT-ND1,"Which gene among SLC25A32, SCGB1D2, MT-ND1, OCIAD1, and ACVR2B-AS1 demonstrates the highest cell-type-specific expression in pancreatic epsilon cells, thereby representing the optimal candidate for targeting in type 1 diabetes mellitus?","Which gene among SLC25A32, SCGB1D2, MT-ND1, OCIAD1, and ACVR2B-AS1 demonstrates the highest cell-type-specific expression in pancreatic epsilon cells, thereby representing the optimal candidate for targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which pancreatic epsilon cell–activated genes in PINNACLE overlap with these targets, defining this overlap as the set of cell-type–specific targets for type 1 diabetes. Compute the average embedding for these genes as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STOX2', 'KIDINS220', 'BEAN1', 'TGM4', 'NDUFA13']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA13,"Which gene among STOX2, KIDINS220, BEAN1, TGM4, and NDUFA13 exhibits the highest specificity in pancreatic epsilon cells with respect to type 1 diabetes mellitus?","Which gene among STOX2, KIDINS220, BEAN1, TGM4, and NDUFA13 exhibits the highest specificity in pancreatic epsilon cells with respect to type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic epsilon cells in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes mellitus. Compute an average embedding from this overlapping set and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LBHD2', 'GOLGA8S', 'NDUFB1', 'LRRK1', 'ADAMTS16']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFB1,"Among the genes LBHD2, GOLGA8S, NDUFB1, LRRK1, and ADAMTS16, which exhibits the most specific expression in pancreatic epsilon cells, making it the most promising candidate for targeting in type 1 diabetes mellitus?","Among the genes LBHD2, GOLGA8S, NDUFB1, LRRK1, and ADAMTS16, which exhibits the most specific expression in pancreatic epsilon cells, making it the most promising candidate for targeting in type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and obtain their cell type–specific embeddings from the PINNACLE database. Determine which targets overlap with genes activated in pancreatic epsilon cells. For the overlapping genes, calculate the average embedding to serve as a reference and then compute the cosine similarity between this reference and each individual gene embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TMSB15A', 'MORC2-AS1', 'COMMD6', 'SLC35F1', 'ARHGEF5']",type 1 diabetes mellitus,pancreatic epsilon cell,COMMD6,"Which gene among TMSB15A, MORC2‐AS1, COMMD6, SLC35F1, and ARHGEF5 demonstrates the highest specificity of expression in pancreatic epsilon cells, making it the most promising candidate for targeting in type 1 diabetes mellitus?","Which gene among TMSB15A, MORC2‐AS1, COMMD6, SLC35F1, and ARHGEF5 demonstrates the highest specificity of expression in pancreatic epsilon cells, making it the most promising candidate for targeting in type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE platform. Next, determine which of these targets overlap with the pancreatic epsilon cell-activated genes in PINNACLE, thereby defining a set of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of these overlapping genes to serve as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise evidence-based rationale for its biological relevance."
"['ZNF564', 'GTSF1', 'INS', 'DIP2C', 'HTR3E']",type 1 diabetes mellitus,pancreatic epsilon cell,INS,"Among the genes ZNF564, GTSF1, INS, DIP2C, and HTR3E, which one exhibits the highest cell-type specificity in pancreatic epsilon cells for targeted intervention in type 1 diabetes mellitus?","Among the genes ZNF564, GTSF1, INS, DIP2C, and HTR3E, which one exhibits the highest cell-type specificity in pancreatic epsilon cells for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic epsilon cells in PINNACLE, thereby defining the cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA1', 'AGBL4', 'SLC12A5-AS1', 'PSG8-AS1', 'TP53TG3D']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA1,"Which gene among NDUFA1, AGBL4, SLC12A5-AS1, PSG8-AS1, and TP53TG3D exhibits the highest specificity for pancreatic ε-cells as a potential therapeutic target for type 1 diabetes mellitus?","Which gene among NDUFA1, AGBL4, SLC12A5-AS1, PSG8-AS1, and TP53TG3D exhibits the highest specificity for pancreatic ε-cells as a potential therapeutic target for type 1 diabetes mellitus? Identify the experimentally validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE database. Next, determine which pancreatic epsilon cell-activated genes in PINNACLE overlap with these targets to form a set of cell-type-specific targets for type 1 diabetes. Calculate the average embedding of this set and compute the cosine similarity between this average and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TRIM34', 'CLEC11A', 'PNO1', 'HS3ST6', 'NDUFS7']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFS7,"Among the genes TRIM34, CLEC11A, PNO1, HS3ST6, and NDUFS7, which one shows the highest specificity for pancreatic epsilon cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes TRIM34, CLEC11A, PNO1, HS3ST6, and NDUFS7, which one shows the highest specificity for pancreatic epsilon cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with pancreatic epsilon cell-activated genes in PINNACLE, thereby defining the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC02811', 'HCFC1-AS1', 'TPRG1-AS1', 'TMEM258', 'GPN1']",type 1 diabetes mellitus,pancreatic epsilon cell,TMEM258,"Which gene among LINC02811, HCFC1-AS1, TPRG1-AS1, TMEM258, and GPN1 exhibits the highest expression specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus?","Which gene among LINC02811, HCFC1-AS1, TPRG1-AS1, TMEM258, and GPN1 exhibits the highest expression specificity in pancreatic epsilon cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which pancreatic epsilon cell-activated genes from PINNACLE overlap with these targets, forming a set of cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['SEC14L2', 'CA11', 'NDUFA11', 'MAST3', 'GDE1']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA11,"Which gene among SEC14L2, CA11, NDUFA11, MAST3, and GDE1 exhibits the highest specificity of expression in pancreatic epsilon cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among SEC14L2, CA11, NDUFA11, MAST3, and GDE1 exhibits the highest specificity of expression in pancreatic epsilon cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic epsilon cells in PINNACLE overlap with these targets to form a cell-type–specific set. Compute the average embedding of this set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DDT', 'SF3B1', 'PCDHA13', 'NCCRP1', 'RPS26']",type 1 diabetes mellitus,pancreatic epsilon cell,RPS26,"Among the genes DDT, SF3B1, PCDHA13, NCCRP1, and RPS26, which one exhibits the highest cell-type-specific expression in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes DDT, SF3B1, PCDHA13, NCCRP1, and RPS26, which one exhibits the highest cell-type-specific expression in pancreatic epsilon cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Determine which genes activated in pancreatic epsilon cells overlap with these targets, representing the cell-type–specific targets for type 1 diabetes mellitus. Then, calculate the average embedding of these overlapping genes and compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SRPK2', 'SATB2', 'TRIM62', 'CALN1', 'NDUFA3']",type 1 diabetes mellitus,pancreatic epsilon cell,NDUFA3,"Which gene among SRPK2, SATB2, TRIM62, CALN1, and NDUFA3 exhibits the highest cell-type specificity in pancreatic epsilon cells relevant to type 1 diabetes mellitus?","Which gene among SRPK2, SATB2, TRIM62, CALN1, and NDUFA3 exhibits the highest cell-type specificity in pancreatic epsilon cells relevant to type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell‐type–specific embeddings from the PINNACLE resource. Next, determine which pancreatic epsilon cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['ZFP62', 'SMIM13', 'TPRKB', 'CPD', 'TPGS1']",type 1 diabetes mellitus,pancreatic d cell,TPGS1,"Which gene among ZFP62, SMIM13, TPRKB, CPD, and TPGS1 exhibits the highest specificity in pancreatic delta cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among ZFP62, SMIM13, TPRKB, CPD, and TPGS1 exhibits the highest specificity in pancreatic delta cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the genes activated in pancreatic d cells as defined by PINNACLE, and identify the overlapping set representing cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['CFL2', 'LINC01522', 'SLC39A3', 'ZNF77', 'AMZ2']",type 1 diabetes mellitus,pancreatic d cell,AMZ2,"Which gene among CFL2, LINC01522, SLC39A3, ZNF77, and AMZ2 exhibits the highest specificity to pancreatic D cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among CFL2, LINC01522, SLC39A3, ZNF77, and AMZ2 exhibits the highest specificity to pancreatic D cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic d cell–activated genes in PINNACLE overlap with these targets, and compute the average embedding for this overlapping set. Calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['FAM228B', 'CHRNB3', 'DDR1', 'BBIP1', 'GADL1']",type 1 diabetes mellitus,pancreatic d cell,DDR1,"Among the genes FAM228B, CHRNB3, DDR1, BBIP1, and GADL1, which exhibits the highest cell-type specificity in pancreatic delta cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes FAM228B, CHRNB3, DDR1, BBIP1, and GADL1, which exhibits the highest cell-type specificity in pancreatic delta cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with PINNACLE’s set of pancreatic δ cell–activated genes. For the overlapping genes, compute the average embedding and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLIRP', 'PDLIM4', 'SELENOF', 'LINC01355', 'DHX9']",type 1 diabetes mellitus,pancreatic d cell,PDLIM4,"Among SLIRP, PDLIM4, SELENOF, LINC01355, and DHX9, which gene exhibits the highest cell-type specificity in pancreatic delta cells relevant to type 1 diabetes mellitus?","Among SLIRP, PDLIM4, SELENOF, LINC01355, and DHX9, which gene exhibits the highest cell-type specificity in pancreatic delta cells relevant to type 1 diabetes mellitus? Retrieve the validated therapeutic targets for type 1 diabetes mellitus along with their cell-type–specific embeddings from PINNACLE. Next, identify which of these targets overlap with the pancreatic d cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set and compute the cosine similarity between the average and each individual target’s embedding. If one gene displays a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GEMIN6', 'CEP68', 'LINC01684', 'PPP3CC', 'NDUFC1']",type 1 diabetes mellitus,pancreatic d cell,NDUFC1,"Among GEMIN6, CEP68, LINC01684, PPP3CC, and NDUFC1, which gene exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus?","Among GEMIN6, CEP68, LINC01684, PPP3CC, and NDUFC1, which gene exhibits the highest cell-type specificity in pancreatic delta cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in pancreatic d cells in PINNACLE. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared with the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA11', 'PIP5K1C', 'PLAC1', 'PLAGL2', 'WRAP53']",type 1 diabetes mellitus,pancreatic d cell,NDUFA11,"Which gene among NDUFA11, PIP5K1C, PLAC1, PLAGL2, and WRAP53 exhibits the most cell-type-specific expression in pancreatic delta cells and represents the most promising target for type 1 diabetes mellitus interventions?","Which gene among NDUFA11, PIP5K1C, PLAC1, PLAGL2, and WRAP53 exhibits the most cell-type-specific expression in pancreatic delta cells and represents the most promising target for type 1 diabetes mellitus interventions? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic d cells overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding for this set, then calculate the cosine similarity between this average and each individual target’s embedding. Finally, if a single gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['LY6G5C', 'CCDC96', 'ABHD12', 'BRWD1', 'H2BC15']",type 1 diabetes mellitus,pancreatic d cell,BRWD1,"Which gene among LY6G5C, CCDC96, ABHD12, BRWD1, and H2BC15 exhibits the highest cell‐type specificity in pancreatic D cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus?","Which gene among LY6G5C, CCDC96, ABHD12, BRWD1, and H2BC15 exhibits the highest cell‐type specificity in pancreatic D cells, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings from PINNACLE. Next, identify the overlap between these targets and genes activated in pancreatic d cells within PINNACLE, defining this intersection as the cell-type-specific targets for type 1 diabetes mellitus. Compute the average embedding of these overlapping targets, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C4orf17', 'FGF12', 'CHD2', 'TMEM59L', 'SRD5A1']",type 1 diabetes mellitus,pancreatic d cell,CHD2,"Which gene among C4orf17, FGF12, CHD2, TMEM59L, and SRD5A1 exhibits the highest cell-type specificity in pancreatic delta cells, making it the most promising candidate for targeted type 1 diabetes mellitus research?","Which gene among C4orf17, FGF12, CHD2, TMEM59L, and SRD5A1 exhibits the highest cell-type specificity in pancreatic delta cells, making it the most promising candidate for targeted type 1 diabetes mellitus research? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which pancreatic d cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for the disease. Calculate the average embedding for this set and compute the cosine similarity between this reference and each individual target embedding. If one gene demonstrates significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation for its biological relevance."
"['RTTN', 'ARL15', 'CLDN7', 'RDH5', 'TPSD1']",type 1 diabetes mellitus,pancreatic d cell,CLDN7,"Among RTTN, ARL15, CLDN7, RDH5, and TPSD1, which gene exhibits the greatest specificity for pancreatic delta cells, making it the most promising target for therapeutic intervention in type 1 diabetes mellitus?","Among RTTN, ARL15, CLDN7, RDH5, and TPSD1, which gene exhibits the greatest specificity for pancreatic delta cells, making it the most promising target for therapeutic intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type-specific embeddings using PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic d-cells to define the cell-type-specific targets. Compute the average embedding of these overlapping targets as a reference, then calculate the cosine similarity between this reference and each target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['CCDC39-AS1', 'SBNO1-AS1', 'KIF4A', 'NME7', 'TCTA']",type 1 diabetes mellitus,pancreatic d cell,TCTA,"Among the genes CCDC39-AS1, SBNO1-AS1, KIF4A, NME7, and TCTA, which one exhibits the highest cell-type specificity in pancreatic delta cells relevant to targeted approaches for type 1 diabetes mellitus?","Among the genes CCDC39-AS1, SBNO1-AS1, KIF4A, NME7, and TCTA, which one exhibits the highest cell-type specificity in pancreatic delta cells relevant to targeted approaches for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the pancreatic d cell–activated genes from PINNACLE, defining the subset of cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this subset, then compute the cosine similarity between this average and the embeddings of each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['LINC01844', 'GPR65', 'NECTIN3', 'CACNA1D', 'LINC01638']",type 1 diabetes mellitus,pancreatic d cell,CACNA1D,"Which gene among LINC01844, GPR65, NECTIN3, CACNA1D, and LINC01638 exhibits the highest specificity in pancreatic d cells, making it the best candidate for targeting type 1 diabetes mellitus?","Which gene among LINC01844, GPR65, NECTIN3, CACNA1D, and LINC01638 exhibits the highest specificity in pancreatic d cells, making it the best candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in pancreatic d cells within PINNACLE. This overlapping set represents the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of these genes, then compute the cosine similarity between this average and the embedding of each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based explanation for its biological significance."
"['CLHC1', 'FKBP1A', 'MMP25-AS1', 'KLF17', 'PPP1R14B-AS1']",type 1 diabetes mellitus,pancreatic d cell,FKBP1A,"Which gene among CLHC1, FKBP1A, MMP25-AS1, KLF17, and PPP1R14B-AS1 exhibits the highest specificity for pancreatic delta cells, making it the prime candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among CLHC1, FKBP1A, MMP25-AS1, KLF17, and PPP1R14B-AS1 exhibits the highest specificity for pancreatic delta cells, making it the prime candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which pancreatic d cell-activated genes in PINNACLE overlap with these targets and compute the average embedding for this overlap set. Calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LIMK2', 'SUDS3', 'MFSD11', 'LIFR-AS1', 'C6orf118']",type 1 diabetes mellitus,pancreatic d cell,SUDS3,"Which gene among LIMK2, SUDS3, MFSD11, LIFR-AS1, and C6orf118 exhibits the highest specificity for pancreatic delta cells in the context of targeting type 1 diabetes mellitus?","Which gene among LIMK2, SUDS3, MFSD11, LIFR-AS1, and C6orf118 exhibits the highest specificity for pancreatic delta cells in the context of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of the pancreatic d cell-activated genes in PINNACLE overlap with these targets to define the cell-type-specific targets for type 1 diabetes. Calculate the average embedding for this set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC7', 'CCDC125', 'ANKRD11', 'IGFBP7', 'STOX1']",type 1 diabetes mellitus,pancreatic d cell,IGFBP7,"Among the genes HDAC7, CCDC125, ANKRD11, IGFBP7, and STOX1, which one exhibits the highest cell-type specificity in pancreatic delta cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes HDAC7, CCDC125, ANKRD11, IGFBP7, and STOX1, which one exhibits the highest cell-type specificity in pancreatic delta cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of pancreatic d cell-activated genes in PINNACLE, thus defining the cell-specific targets for the disease. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['PMM2', 'APOBEC3G', 'CA9', 'MRPL9', 'NDUFA8']",type 1 diabetes mellitus,pancreatic d cell,NDUFA8,"Which gene among PMM2, APOBEC3G, CA9, MRPL9, and NDUFA8 exhibits the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus targeting?","Which gene among PMM2, APOBEC3G, CA9, MRPL9, and NDUFA8 exhibits the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus targeting? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic D cells (as recorded in PINNACLE) overlap with these targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BTRC', 'RSBN1', 'SRGAP2', 'FAR1', 'DOCK6']",type 1 diabetes mellitus,pancreatic d cell,RSBN1,"Which gene among BTRC, RSBN1, SRGAP2, FAR1, and DOCK6 exhibits the highest specificity in pancreatic D cells with direct relevance to type 1 diabetes mellitus?","Which gene among BTRC, RSBN1, SRGAP2, FAR1, and DOCK6 exhibits the highest specificity in pancreatic D cells with direct relevance to type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Then, from the set of pancreatic d cell-activated genes in PINNACLE, determine which ones overlap with these targets to define the candidate cell-type-specific targets. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target. If a single gene exhibits a substantially higher similarity than the others, nominate it as the best candidate and provide a concise, evidence-based rationale for its biological relevance."
"['VPS16', 'PCAT18', 'RPS18', 'LINC02382', 'MIEN1']",type 1 diabetes mellitus,pancreatic d cell,MIEN1,"Which gene—VPS16, PCAT18, RPS18, LINC02382, or MIEN1—displays the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus?","Which gene—VPS16, PCAT18, RPS18, LINC02382, or MIEN1—displays the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic d cell–activated genes in PINNACLE overlap with these targets, defining the resulting set as the cell-type–specific targets for type 1 diabetes. Calculate the average embedding from this set and compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['LRRC19', 'PRC1', 'ELMOD1', 'TCEAL6', 'M6PR']",type 1 diabetes mellitus,pancreatic d cell,M6PR,"Which gene among LRRC19, PRC1, ELMOD1, TCEAL6, and M6PR demonstrates the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus?","Which gene among LRRC19, PRC1, ELMOD1, TCEAL6, and M6PR demonstrates the highest specificity for pancreatic delta cells in the context of type 1 diabetes mellitus? Identify the verified therapeutic gene targets for type 1 diabetes mellitus using cell-type–specific embeddings from the PINNACLE database. Then, determine which of these targets overlap with the genes activated in pancreatic d cells from PINNACLE. Calculate the average embedding for this overlapping gene set and compute the cosine similarity between this reference and each individual target. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS2', 'NMRK2', 'NTF3', 'SEMA4C', 'SLC26A4-AS1']",type 1 diabetes mellitus,pancreatic d cell,NDUFS2,"Among the genes NDUFS2, NMRK2, NTF3, SEMA4C, and SLC26A4-AS1, which one exhibits the highest specificity for pancreatic delta cells, making it the most promising target for type 1 diabetes mellitus therapy?","Among the genes NDUFS2, NMRK2, NTF3, SEMA4C, and SLC26A4-AS1, which one exhibits the highest specificity for pancreatic delta cells, making it the most promising target for type 1 diabetes mellitus therapy? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Determine which targets overlap with the pancreatic d cell-activated genes in PINNACLE, and compute the average embedding of this overlapping set. Next, calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits notably higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based justification for its biological relevance."
"['ZNF878', 'NUDT10', 'C17orf97', 'PTEN', 'BPHL']",type 1 diabetes mellitus,pancreatic d cell,PTEN,"Among ZNF878, NUDT10, C17orf97, PTEN, and BPHL, which gene exhibits the highest cell-type specificity in pancreatic delta cells relative to its potential role in type 1 diabetes mellitus?","Among ZNF878, NUDT10, C17orf97, PTEN, and BPHL, which gene exhibits the highest cell-type specificity in pancreatic delta cells relative to its potential role in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the pancreatic d cell–activated genes in PINNACLE, thereby defining a candidate set. Compute the average embedding from this set as a reference, and calculate the cosine similarity between this reference and each individual candidate gene. If one gene exhibits a substantially higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['CA12', 'ZNF283', 'TBC1D9', 'LINC02004', 'IRAK4']",type 1 diabetes mellitus,pancreatic ductal cell,CA12,"Among CA12, ZNF283, TBC1D9, LINC02004, and IRAK4, which gene exhibits the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeting type 1 diabetes mellitus?","Among CA12, ZNF283, TBC1D9, LINC02004, and IRAK4, which gene exhibits the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic ductal cells overlap with these targets. For the overlapping genes, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target's embedding. Finally, nominate the gene with the highest similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF516-DT', 'SAMD9', 'SPIRE1', 'LINC01772', 'SIGLEC9']",type 1 diabetes mellitus,pancreatic ductal cell,SPIRE1,"Which gene among ZNF516-DT, SAMD9, SPIRE1, LINC01772, and SIGLEC9 exhibits the highest specificity for pancreatic ductal cells as a target in type 1 diabetes mellitus?","Which gene among ZNF516-DT, SAMD9, SPIRE1, LINC01772, and SIGLEC9 exhibits the highest specificity for pancreatic ductal cells as a target in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic ductal cells within PINNACLE. Compute the average embedding of the overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-DQB1', 'MADD', 'FAM76A', 'PNMA8B', 'GTF3C2-AS1']",type 1 diabetes mellitus,pancreatic ductal cell,HLA-DQB1,"Which gene among HLA-DQB1, MADD, FAM76A, PNMA8B, and GTF3C2-AS1 exhibits the highest specificity for pancreatic ductal cells, thereby representing the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among HLA-DQB1, MADD, FAM76A, PNMA8B, and GTF3C2-AS1 exhibits the highest specificity for pancreatic ductal cells, thereby representing the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify experimentally validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells within the database. Calculate the average embedding of the overlapping set as a composite reference, then compute the cosine similarity between each individual target embedding and this reference. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SKAP2', 'OAZ2', 'FGF18', 'PAN3', 'MRPL51']",type 1 diabetes mellitus,pancreatic ductal cell,SKAP2,"Which gene among SKAP2, OAZ2, FGF18, PAN3, and MRPL51 demonstrates the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus?","Which gene among SKAP2, OAZ2, FGF18, PAN3, and MRPL51 demonstrates the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection of these targets with the pancreatic ductal cell–activated genes present in PINNACLE to establish a set of cell-type–specific targets. Compute the average embedding for this subset, then calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PAFAH2', 'KIAA0319L', 'SNIP1', 'PRANCR', 'NXPE2']",type 1 diabetes mellitus,pancreatic ductal cell,KIAA0319L,"Which gene among PAFAH2, KIAA0319L, SNIP1, PRANCR, and NXPE2 exhibits the highest specificity in pancreatic ductal cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among PAFAH2, KIAA0319L, SNIP1, PRANCR, and NXPE2 exhibits the highest specificity in pancreatic ductal cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes and retrieve their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in pancreatic ductal cells, and use this overlapping set as the basis for cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LUC7L2', 'PSG5', 'DDR1', 'NFIC', 'OS9']",type 1 diabetes mellitus,pancreatic ductal cell,DDR1,"Which gene among LUC7L2, PSG5, DDR1, NFIC, and OS9 exhibits the highest specificity for pancreatic ductal cells and could therefore serve as the most promising candidate for type 1 diabetes mellitus targeting?","Which gene among LUC7L2, PSG5, DDR1, NFIC, and OS9 exhibits the highest specificity for pancreatic ductal cells and could therefore serve as the most promising candidate for type 1 diabetes mellitus targeting? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic ductal cells overlap with these targets. For this overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFAF1', 'ODF3B', 'IVNS1ABP', 'C21orf58', 'LINC00957']",type 1 diabetes mellitus,pancreatic ductal cell,NDUFAF1,"Which gene among NDUFAF1, ODF3B, IVNS1ABP, C21orf58, and LINC00957 exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among NDUFAF1, ODF3B, IVNS1ABP, C21orf58, and LINC00957 exhibits the highest cell-type specificity in pancreatic ductal cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which pancreatic ductal cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between the average embedding and each individual target's embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['BEST4', 'TTC26', 'C4orf33', 'SPRR2F', 'LINC02634']",type 1 diabetes mellitus,pancreatic ductal cell,C4orf33,"Among the genes BEST4, TTC26, C4orf33, SPRR2F, and LINC02634, which one exhibits the highest specificity for pancreatic ductal cells, making it the most promising target for type 1 diabetes mellitus?","Among the genes BEST4, TTC26, C4orf33, SPRR2F, and LINC02634, which one exhibits the highest specificity for pancreatic ductal cells, making it the most promising target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the genes activated in pancreatic ductal cells according to PINNACLE. Calculate the average embedding for the overlapping targets and determine the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BTF3L4', 'PCDHB12', 'LINC01821', 'IRF2', 'SLC49A4']",type 1 diabetes mellitus,pancreatic ductal cell,IRF2,"Among the genes BTF3L4, PCDHB12, LINC01821, IRF2, and SLC49A4, which one exhibits the highest specificity for pancreatic ductal cells in the context of type 1 diabetes mellitus?","Among the genes BTF3L4, PCDHB12, LINC01821, IRF2, and SLC49A4, which one exhibits the highest specificity for pancreatic ductal cells in the context of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic ductal cell-activated genes in the same database. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this reference embedding and the embedding of each individual target. Finally, if one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['LINC01521', 'RPL6', 'NDUFB8', 'NHS', 'RFESD']",type 1 diabetes mellitus,pancreatic ductal cell,NDUFB8,"Which gene among LINC01521, RPL6, NDUFB8, NHS, and RFESD exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus?","Which gene among LINC01521, RPL6, NDUFB8, NHS, and RFESD exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus? Identify the therapeutic targets for type 1 diabetes mellitus that have been validated and obtain their cell-type–specific embeddings from the PINNACLE database. From these, determine which targets overlap with genes activated in pancreatic ductal cells according to PINNACLE. Compute the average embedding for this overlapping gene set and then calculate the cosine similarity between the average embedding and each individual overlapping target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['FOLR1', 'CUEDC2', 'LURAP1L', 'SKP2', 'UBXN8']",type 1 diabetes mellitus,pancreatic ductal cell,LURAP1L,"Which gene among FOLR1, CUEDC2, LURAP1L, SKP2, and UBXN8 demonstrates the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among FOLR1, CUEDC2, LURAP1L, SKP2, and UBXN8 demonstrates the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are present among the pancreatic ductal cell–activated genes in PINNACLE, and compute an average embedding for this overlapping set. Then, calculate the cosine similarity between the average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CAHM', 'FBH1', 'RNASEH1', 'ITGA6-AS1', 'ZNF805']",type 1 diabetes mellitus,pancreatic ductal cell,FBH1,"Among CAHM, FBH1, RNASEH1, ITGA6-AS1, and ZNF805, which gene demonstrates the highest cell type-specific expression in pancreatic ductal cells for targeting type 1 diabetes mellitus?","Among CAHM, FBH1, RNASEH1, ITGA6-AS1, and ZNF805, which gene demonstrates the highest cell type-specific expression in pancreatic ductal cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the subset of these targets that also appears among the pancreatic ductal cell-activated genes in PINNACLE. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average embedding and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ELAVL4', 'PPIA', 'KAT8', 'WWP1', 'ATP13A2']",type 1 diabetes mellitus,pancreatic ductal cell,PPIA,"Among the genes ELAVL4, PPIA, KAT8, WWP1, and ATP13A2, which shows the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeting type 1 diabetes mellitus?","Among the genes ELAVL4, PPIA, KAT8, WWP1, and ATP13A2, which shows the most specific expression in pancreatic ductal cells, making it the optimal candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic ductal cell-activated genes in PINNACLE overlap with these targets. For this overlapping set, calculate the average embedding as a reference point and compute the cosine similarity between this reference and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological significance."
"['SEPHS1', 'LBHD1', 'MRPL12', 'COQ5', 'STEAP1']",type 1 diabetes mellitus,pancreatic ductal cell,STEAP1,"Which gene among SEPHS1, LBHD1, MRPL12, COQ5, and STEAP1 exhibits the highest cell-type specificity in pancreatic ductal cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among SEPHS1, LBHD1, MRPL12, COQ5, and STEAP1 exhibits the highest cell-type specificity in pancreatic ductal cells, making it the optimal candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in pancreatic ductal cells, defining this intersection as the cell-type–specific targets for T1D. Compute the average embedding for these genes and calculate the cosine similarity between this average and each individual target's embedding. Finally, nominate the gene with the highest similarity as the prime candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['FAT2', 'ARF4-AS1', 'LINC00184', 'SDCBP', 'MT-ND2']",type 1 diabetes mellitus,pancreatic ductal cell,MT-ND2,"Among the genes FAT2, ARF4-AS1, LINC00184, SDCBP, and MT-ND2, which one demonstrates the highest cell-type specificity in pancreatic ductal cells relevant to type 1 diabetes mellitus?","Among the genes FAT2, ARF4-AS1, LINC00184, SDCBP, and MT-ND2, which one demonstrates the highest cell-type specificity in pancreatic ductal cells relevant to type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and genes activated in pancreatic ductal cells. For the overlapping genes, calculate their average embedding as a reference vector and compute the cosine similarity between this reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBM12', 'KDM2B', 'UBLCP1', 'LRRC71', 'BIRC6-AS1']",type 1 diabetes mellitus,pancreatic ductal cell,UBLCP1,"Which gene—RBM12, KDM2B, UBLCP1, LRRC71, or BIRC6-AS1—demonstrates the highest specific expression in pancreatic ductal cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene—RBM12, KDM2B, UBLCP1, LRRC71, or BIRC6-AS1—demonstrates the highest specific expression in pancreatic ductal cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic ductal cells overlap with these targets. For the overlapping set, compute the average embedding to serve as a reference and then calculate the cosine similarity between this reference and each individual gene’s embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SEC14L5', 'NUDC', 'SMARCE1', 'PAFAH1B1', 'GRIN1']",type 1 diabetes mellitus,pancreatic ductal cell,SMARCE1,"Which gene among SEC14L5, NUDC, SMARCE1, PAFAH1B1, and GRIN1 exhibits the highest cell-type specificity in pancreatic ductal cells for developing therapeutic strategies for type 1 diabetes mellitus?","Which gene among SEC14L5, NUDC, SMARCE1, PAFAH1B1, and GRIN1 exhibits the highest cell-type specificity in pancreatic ductal cells for developing therapeutic strategies for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, identify the subset of these targets that overlap with genes activated in pancreatic ductal cells in PINNACLE. For this overlapping set, calculate the average embedding as a reference and determine the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['MEIG1', 'MARCHF7', 'CACNG4', 'KIAA2013', 'ADRA2C']",type 1 diabetes mellitus,pancreatic ductal cell,ADRA2C,"Among the genes MEIG1, MARCHF7, CACNG4, KIAA2013, and ADRA2C, which one exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus?","Among the genes MEIG1, MARCHF7, CACNG4, KIAA2013, and ADRA2C, which one exhibits the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type specific embeddings from the PINNACLE dataset. Next, determine which genes activated in pancreatic ductal cells within PINNACLE overlap with these targets, thereby defining a set of cell-type specific targets for this disease. Compute the average embedding of this overlap and then calculate the cosine similarity between the reference embedding and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SUN3', 'GET3', 'TPCN1', 'SUCO', 'TRMT44']",type 1 diabetes mellitus,pancreatic ductal cell,SUCO,"Among the genes SUN3, GET3, TPCN1, SUCO, and TRMT44, which demonstrates the highest cell-type specificity in pancreatic ductal cells to serve as a potential target for type 1 diabetes mellitus?","Among the genes SUN3, GET3, TPCN1, SUCO, and TRMT44, which demonstrates the highest cell-type specificity in pancreatic ductal cells to serve as a potential target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the pancreatic ductal cell-activated genes in PINNACLE overlap with these targets to form a set of cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding for this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['FER1L6', 'MT-ND1', 'CSF2RA_ENSG00000198223', 'TOMM20', 'TGS1']",type 1 diabetes mellitus,pancreatic ductal cell,MT-ND1,"Which gene—FER1L6, MT-ND1, CSF2RA_ENSG00000198223, TOMM20, or TGS1—displays the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus?","Which gene—FER1L6, MT-ND1, CSF2RA_ENSG00000198223, TOMM20, or TGS1—displays the highest cell-type specificity in pancreatic ductal cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which pancreatic ductal cell-activated genes in PINNACLE overlap with these therapeutic targets to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM60', 'RANBP3L', 'ABHD15', 'MMD', 'MTCH1']",type 1 diabetes mellitus,endothelial cell,MTCH1,"Among the candidate genes TMEM60, RANBP3L, ABHD15, MMD, and MTCH1, which one exhibits the highest endothelial cell specificity as a target for type 1 diabetes mellitus?","Among the candidate genes TMEM60, RANBP3L, ABHD15, MMD, and MTCH1, which one exhibits the highest endothelial cell specificity as a target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the endothelial cell–activated genes in PINNACLE. Next, calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LSM2', 'SF3B4', 'CMBL', 'EEFSEC', 'SLC1A5']",type 1 diabetes mellitus,endothelial cell,SLC1A5,"Among the genes LSM2, SF3B4, CMBL, EEFSEC, and SLC1A5, which one demonstrates the highest endothelial cell specificity relevant to targeting type 1 diabetes mellitus?","Among the genes LSM2, SF3B4, CMBL, EEFSEC, and SLC1A5, which one demonstrates the highest endothelial cell specificity relevant to targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the endothelial cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this reference vector and the embedding of each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KXD1', 'TM9SF3', 'ABTB2', 'FSCN1', 'LTBP2']",type 1 diabetes mellitus,endothelial cell,FSCN1,"Among KXD1, TM9SF3, ABTB2, FSCN1, and LTBP2, which gene exhibits the highest endothelial cell-specific expression relevant to targeting type 1 diabetes mellitus?","Among KXD1, TM9SF3, ABTB2, FSCN1, and LTBP2, which gene exhibits the highest endothelial cell-specific expression relevant to targeting type 1 diabetes mellitus? Determine the verified therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type–specific embeddings from PINNACLE. Identify which endothelial cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding from the overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SHF', 'INS', 'SPRR1A', 'LINC01204', 'RHOV']",type 1 diabetes mellitus,endothelial cell,INS,"Among the genes SHF, INS, SPRR1A, LINC01204, and RHOV, which one exhibits the highest endothelial cell-specific expression and represents the most promising target for therapeutic intervention in type 1 diabetes mellitus?","Among the genes SHF, INS, SPRR1A, LINC01204, and RHOV, which one exhibits the highest endothelial cell-specific expression and represents the most promising target for therapeutic intervention in type 1 diabetes mellitus? Using PINNACLE, identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with genes activated in endothelial cells within the dataset. Using this overlapping set, compute an average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['NKX2-3', 'C9orf64', 'PLA2G2D', 'SMYD5', 'RBM8A']",type 1 diabetes mellitus,endothelial cell,NKX2-3,"Among the genes NKX2-3, C9orf64, PLA2G2D, SMYD5, and RBM8A, which one shows the highest endothelial cell-specific expression potentially relevant for targeting type 1 diabetes mellitus?","Among the genes NKX2-3, C9orf64, PLA2G2D, SMYD5, and RBM8A, which one shows the highest endothelial cell-specific expression potentially relevant for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with PINNACLE’s endothelial cell‑activated gene set, establishing the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence‑based rationale for its biological relevance."
"['SEC61G', 'FAM225A', 'NDUFB4', 'RAB8A', 'TSSK4']",type 1 diabetes mellitus,endothelial cell,NDUFB4,"Which gene among SEC61G, FAM225A, NDUFB4, RAB8A, and TSSK4 exhibits the highest endothelial cell specificity that could serve as a targeted candidate for type 1 diabetes mellitus interventions?","Which gene among SEC61G, FAM225A, NDUFB4, RAB8A, and TSSK4 exhibits the highest endothelial cell specificity that could serve as a targeted candidate for type 1 diabetes mellitus interventions? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell–activated genes in PINNACLE intersect with these targets to yield a set of cell-type–specific targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and the individual target embeddings. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LGALS8', 'IL1R1', 'BACE2-IT1', 'XAF1', 'LINC00930']",type 1 diabetes mellitus,endothelial cell,IL1R1,"Which gene among LGALS8, IL1R1, BACE2-IT1, XAF1, and LINC00930 exhibits the highest specificity of expression in endothelial cells relevant to targeting type 1 diabetes mellitus?","Which gene among LGALS8, IL1R1, BACE2-IT1, XAF1, and LINC00930 exhibits the highest specificity of expression in endothelial cells relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the endothelial cell-activated genes in PINNACLE. Calculate the average embedding of the overlapping targets and measure the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the rest, nominate it as the top candidate, providing a brief, evidence-based explanation of its biological relevance."
"['LUCAT1', 'NDUFA11', 'CCP110', 'ASTE1', 'UNC5A']",type 1 diabetes mellitus,endothelial cell,NDUFA11,"Which gene among LUCAT1, NDUFA11, CCP110, ASTE1, and UNC5A exhibits the highest endothelial cell-specific expression, making it the optimal candidate for targeted studies in type 1 diabetes mellitus?","Which gene among LUCAT1, NDUFA11, CCP110, ASTE1, and UNC5A exhibits the highest endothelial cell-specific expression, making it the optimal candidate for targeted studies in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of endothelial cell-activated genes in PINNACLE. Calculate the average embedding for the overlapping targets and compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPTBN5', 'ARHGEF17', 'MYL6', 'ZFP30', 'NDUFC2']",type 1 diabetes mellitus,endothelial cell,NDUFC2,"Among the genes SPTBN5, ARHGEF17, MYL6, ZFP30, and NDUFC2, which exhibits the highest endothelial cell-specific expression relevant to targeting type 1 diabetes mellitus?","Among the genes SPTBN5, ARHGEF17, MYL6, ZFP30, and NDUFC2, which exhibits the highest endothelial cell-specific expression relevant to targeting type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Cross-reference these targets with the set of endothelial cell-activated genes provided in PINNACLE to identify overlapping candidates. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual gene’s embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CROCC2', 'BCAS4', 'EXOSC3', 'A2M', 'MIP']",type 1 diabetes mellitus,endothelial cell,A2M,"Which gene among CROCC2, BCAS4, EXOSC3, A2M, and MIP exhibits the highest endothelial cell-specific expression, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus?","Which gene among CROCC2, BCAS4, EXOSC3, A2M, and MIP exhibits the highest endothelial cell-specific expression, making it the most promising candidate for targeted therapy in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the endothelial cell–activated genes in PINNACLE to obtain the cell-type–specific targets for T1DM. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MPRIP-AS1', 'CTBP1-DT', 'RPUSD2', 'HSPA6', 'RBM17']",type 1 diabetes mellitus,endothelial cell,RBM17,"Which gene among MPRIP-AS1, CTBP1-DT, RPUSD2, HSPA6, and RBM17 demonstrates the highest endothelial cell type-specific expression, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among MPRIP-AS1, CTBP1-DT, RPUSD2, HSPA6, and RBM17 demonstrates the highest endothelial cell type-specific expression, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, obtain the list of endothelial cell–activated genes from PINNACLE and identify the overlapping set with the therapeutic targets. For these overlapping genes, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PABIR2', 'H4C3', 'BIN3', 'LINC01812', 'CLTA']",type 1 diabetes mellitus,endothelial cell,H4C3,"Which gene—PABIR2', H4C3, BIN3, LINC01812, or CLTA—displays the highest endothelial cell-specific expression profile for potential targeting of type 1 diabetes mellitus?","Which gene—PABIR2', H4C3, BIN3, LINC01812, or CLTA—displays the highest endothelial cell-specific expression profile for potential targeting of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell–activated genes in PINNACLE overlap with these targets to establish a refined list of cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BRINP3', 'SLC12A9', 'RHPN2', 'EID1', 'C8orf88']",type 1 diabetes mellitus,endothelial cell,EID1,"Among the candidate genes (BRINP3, SLC12A9, RHPN2, EID1, and C8orf88), which demonstrates the highest endothelial cell specificity relevant to targeting type 1 diabetes mellitus?","Among the candidate genes (BRINP3, SLC12A9, RHPN2, EID1, and C8orf88), which demonstrates the highest endothelial cell specificity relevant to targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes upregulated in endothelial cells as recorded in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target's embedding. If a single gene demonstrates significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KLF3', 'NUGGC', 'NHSL1', 'HDAC11-AS1', 'CAPN9']",type 1 diabetes mellitus,endothelial cell,KLF3,"Which gene among KLF3, NUGGC, NHSL1, HDAC11-AS1, and CAPN9 exhibits the highest endothelial cell-type specificity for potential therapeutic targeting in type 1 diabetes mellitus?","Which gene among KLF3, NUGGC, NHSL1, HDAC11-AS1, and CAPN9 exhibits the highest endothelial cell-type specificity for potential therapeutic targeting in type 1 diabetes mellitus? Identify confirmed therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are among the endothelial cell–activated genes identified in PINNACLE. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity score compared to the others, nominate it as the primary candidate and provide a concise, evidence-based explanation for its biological relevance in type 1 diabetes mellitus."
"['MAST4-AS1', 'MAP3K20-AS1', 'NDUFC1', 'R3HDM1', 'NR2F2-AS1']",type 1 diabetes mellitus,endothelial cell,NDUFC1,"Which gene among MAST4-AS1, MAP3K20-AS1, NDUFC1, R3HDM1, and NR2F2-AS1 exhibits the highest expression specificity in endothelial cells, suggesting its suitability as a potential target for type 1 diabetes mellitus?","Which gene among MAST4-AS1, MAP3K20-AS1, NDUFC1, R3HDM1, and NR2F2-AS1 exhibits the highest expression specificity in endothelial cells, suggesting its suitability as a potential target for type 1 diabetes mellitus? Using verified therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type–specific embeddings from the PINNACLE dataset. Identify which of these targets overlap with endothelial cell–activated genes to define a set of cell-type–specific T1D targets. Next, compute the average embedding of this set to serve as a reference, and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACAT2', 'EHMT2-AS1', 'CCNA1', 'TMEM258', 'C22orf31']",type 1 diabetes mellitus,endothelial cell,TMEM258,"Which gene—ACAT2, EHMT2-AS1, CCNA1, TMEM258, or C22orf31—displays the highest endothelial cell-type specificity relevant for targeting type 1 diabetes mellitus?","Which gene—ACAT2, EHMT2-AS1, CCNA1, TMEM258, or C22orf31—displays the highest endothelial cell-type specificity relevant for targeting type 1 diabetes mellitus? Identify confirmed therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap with endothelial cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this group and assess the cosine similarity between this reference and each individual target. If one gene shows a distinctly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SLC10A5', 'GNL3', 'PTPN11', 'B4GALT1-AS1', 'PXMP4']",type 1 diabetes mellitus,endothelial cell,PTPN11,"Among the genes SLC10A5, GNL3, PTPN11, B4GALT1-AS1, and PXMP4, which exhibits the highest endothelial cell–specific expression relevant to type 1 diabetes mellitus?","Among the genes SLC10A5, GNL3, PTPN11, B4GALT1-AS1, and PXMP4, which exhibits the highest endothelial cell–specific expression relevant to type 1 diabetes mellitus? For type 1 diabetes mellitus, identify experimentally validated therapeutic targets and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF561', 'ERBIN', 'NDUFA3', 'MAGEH1', 'CDO1']",type 1 diabetes mellitus,endothelial cell,NDUFA3,"Which gene among ZNF561, ERBIN, NDUFA3, MAGEH1, and CDO1 exhibits the highest specificity for endothelial cells in the context of type 1 diabetes mellitus?","Which gene among ZNF561, ERBIN, NDUFA3, MAGEH1, and CDO1 exhibits the highest specificity for endothelial cells in the context of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell–activated genes in PINNACLE to define a set of cell-type–specific targets for the disease. Calculate the average embedding for this overlapping set and determine the cosine similarity of each individual gene’s embedding to the average. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MDS2', 'HOXD10', 'HLA-DRB1', 'CPPED1', 'LINC01123']",type 1 diabetes mellitus,endothelial cell,HLA-DRB1,"Among the genes MDS2, HOXD10, HLA-DRB1, CPPED1, and LINC01123, which shows the highest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus?","Among the genes MDS2, HOXD10, HLA-DRB1, CPPED1, and LINC01123, which shows the highest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the genes activated in endothelial cells according to PINNACLE; this overlapping set will represent the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this set as a reference, and calculate the cosine similarity between the reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['CDK6-AS1', 'M6PR', 'PDE1C', 'LINC01742', 'CALB2']",type 1 diabetes mellitus,endothelial cell,M6PR,"Which gene, from the list CDK6-AS1, M6PR, PDE1C, LINC01742, and CALB2, exhibits the highest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus?","Which gene, from the list CDK6-AS1, M6PR, PDE1C, LINC01742, and CALB2, exhibits the highest specificity for endothelial cells in the context of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the endothelial cell–activated genes cataloged in PINNACLE. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPRY1', 'GRM7', 'M6PR', 'NALCN', 'AGR2']",type 1 diabetes mellitus,unknown,M6PR,"Which gene among SPRY1, GRM7, M6PR, NALCN, and AGR2 exhibits the highest degree of cell-type-specific expression in tissues relevant to type 1 diabetes mellitus?","Which gene among SPRY1, GRM7, M6PR, NALCN, and AGR2 exhibits the highest degree of cell-type-specific expression in tissues relevant to type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which unknown-activated genes overlap with these targets to define the cell-type–specific target set. Calculate the average embedding for this set, then determine the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TANK-AS1', 'IL6ST', 'PPM1H', 'LINC02603', 'ARL17B']",type 1 diabetes mellitus,unknown,IL6ST,"Among TANK-AS1, IL6ST, PPM1H, LINC02603, and ARL17B, which gene exhibits the highest degree of cell-type specificity and holds the most promise as a target for type 1 diabetes mellitus?","Among TANK-AS1, IL6ST, PPM1H, LINC02603, and ARL17B, which gene exhibits the highest degree of cell-type specificity and holds the most promise as a target for type 1 diabetes mellitus? For type 1 diabetes mellitus, identify verified therapeutic targets and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which unknown-activated genes in PINNACLE overlap with these targets, thereby defining cell-type–specific targets. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PRR14', 'GRAMD1C', 'DIRAS2', 'TSC1', 'CNN3']",type 1 diabetes mellitus,unknown,DIRAS2,"Among PRR14, GRAMD1C, DIRAS2, TSC1, and CNN3, which gene demonstrates the highest cell-type specificity and appears most promising as a therapeutic target for type 1 diabetes mellitus?","Among PRR14, GRAMD1C, DIRAS2, TSC1, and CNN3, which gene demonstrates the highest cell-type specificity and appears most promising as a therapeutic target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which unknown activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding of this set as a reference, then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LINC00336', 'TRBV28', 'NDUFAF2', 'ZNF419', 'CHD8']",type 1 diabetes mellitus,unknown,NDUFAF2,"Which gene among LINC00336, TRBV28, NDUFAF2, ZNF419, and CHD8 exhibits the highest cell type-specific expression, making it the strongest candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among LINC00336, TRBV28, NDUFAF2, ZNF419, and CHD8 exhibits the highest cell type-specific expression, making it the strongest candidate for targeted intervention in type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the unknown-activated genes in PINNACLE to define the cell-type–specific target set. Compute the average embedding of this set as a reference, and then calculate the cosine similarity between this reference and each target gene. Should one gene display a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ZFHX2', 'PTPN9', 'TRIM3', 'IRF1', 'C1orf167-AS1']",type 1 diabetes mellitus,unknown,IRF1,"Which gene among ZFHX2, PTPN9, TRIM3, IRF1, and C1orf167-AS1 exhibits the greatest cell-type specificity and is the most promising candidate as a therapeutic target for type 1 diabetes mellitus?","Which gene among ZFHX2, PTPN9, TRIM3, IRF1, and C1orf167-AS1 exhibits the greatest cell-type specificity and is the most promising candidate as a therapeutic target for type 1 diabetes mellitus? Retrieve the verified therapeutic gene targets for type 1 diabetes mellitus along with their cell-type–specific embeddings from PINNACLE. Then, identify the overlap between these known targets and the set of unknown-activated genes in PINNACLE, defining this intersection as the cell-type–specific therapeutic targets. Calculate the average embedding for these overlapping targets as a reference point, and compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['SEC61A1', 'UBLCP1', 'RNF7', 'ICAM2', 'SRM']",type 1 diabetes mellitus,unknown,UBLCP1,"Among the genes SEC61A1, UBLCP1, RNF7, ICAM2, and SRM, which exhibits the highest cell-type specificity, making it the most promising target for intervention in type 1 diabetes mellitus?","Among the genes SEC61A1, UBLCP1, RNF7, ICAM2, and SRM, which exhibits the highest cell-type specificity, making it the most promising target for intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus from the PINNACLE database and obtain their cell-type–specific embeddings. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for this disease. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACYP1', 'CDC16', 'SSBP3-AS1', 'H4C3', 'LIMS3']",type 1 diabetes mellitus,unknown,H4C3,"Which gene among ACYP1, CDC16, SSBP3-AS1, H4C3, and LIMS3 exhibits the highest degree of cell-type-specific expression, making it the most promising candidate for targeted investigations in type 1 diabetes mellitus?","Which gene among ACYP1, CDC16, SSBP3-AS1, H4C3, and LIMS3 exhibits the highest degree of cell-type-specific expression, making it the most promising candidate for targeted investigations in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Determine the intersection between these targets and the set of unknown-activated genes in PINNACLE, defining the cell-type–specific targets for type 1 diabetes. Compute the mean embedding of this intersection set and calculate the cosine similarity between this average embedding and each individual target embedding. If one gene exhibits a notably higher cosine similarity than the others, nominate it as the top candidate, providing a brief, evidence-based rationale for its biological relevance."
"['NOP9', 'TTC8', 'SH3GL3', 'CCDC25', 'LINC02574']",type 1 diabetes mellitus,unknown,TTC8,"Which gene among NOP9, TTC8, SH3GL3, CCDC25, and LINC02574 exhibits the highest degree of cell-type-specific expression in the context of type 1 diabetes mellitus, making it the most promising candidate for targeted intervention?","Which gene among NOP9, TTC8, SH3GL3, CCDC25, and LINC02574 exhibits the highest degree of cell-type-specific expression in the context of type 1 diabetes mellitus, making it the most promising candidate for targeted intervention? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes in PINNACLE’s unknown-activated set overlap with these targets to define cell-type–specific targets. Calculate the average embedding for these targets and compute the cosine similarity between this composite reference and each individual target embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['GJC2', 'CCDC73', 'MTMR3', 'CAPS', 'HNMT']",type 1 diabetes mellitus,unknown,MTMR3,"Among the genes GJC2, CCDC73, MTMR3, CAPS, and HNMT, which one exhibits the highest cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, thereby representing the best candidate for targeted intervention?","Among the genes GJC2, CCDC73, MTMR3, CAPS, and HNMT, which one exhibits the highest cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, thereby representing the best candidate for targeted intervention? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for the disease. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ODF1', 'FOXN3', 'LINC00484_ENSG00000229694', 'LYST', 'WDR44']",type 1 diabetes mellitus,unknown,FOXN3,"Which gene among ODF1, FOXN3, LINC00484_ENSG00000229694, LYST, and WDR44 exhibits the highest cell-type specificity for therapeutic targeting in type 1 diabetes mellitus?","Which gene among ODF1, FOXN3, LINC00484_ENSG00000229694, LYST, and WDR44 exhibits the highest cell-type specificity for therapeutic targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type specific embeddings from the PINNACLE database. Then, determine the overlap between these targets and the uncharacterized activated genes in PINNACLE. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['BRAF', 'EPHA5-AS1', 'WDR73', 'MCCD1', 'EXPH5']",type 1 diabetes mellitus,unknown,BRAF,"Among the genes BRAF, EPHA5-AS1, WDR73, MCCD1, and EXPH5, which exhibits the highest cell-type specificity for targeting type 1 diabetes mellitus?","Among the genes BRAF, EPHA5-AS1, WDR73, MCCD1, and EXPH5, which exhibits the highest cell-type specificity for targeting type 1 diabetes mellitus? Retrieve the cell-type–specific embeddings of verified therapeutic targets for type 1 diabetes mellitus from PINNACLE. Identify which unknown-activated genes overlap with these targets to define a set of cell-type–specific T1DM targets. Compute the average embedding of this overlap and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TMF1', 'MCF2', 'BCL7A', 'NDUFB3', 'SDSL']",type 1 diabetes mellitus,unknown,NDUFB3,"Among the genes TMF1, MCF2, BCL7A, NDUFB3, and SDSL, which one exhibits the highest cell-type specificity in tissues relevant to type 1 diabetes mellitus targeted therapies?","Among the genes TMF1, MCF2, BCL7A, NDUFB3, and SDSL, which one exhibits the highest cell-type specificity in tissues relevant to type 1 diabetes mellitus targeted therapies? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which unknown activated genes within PINNACLE overlap with these targets to define a cell-specific target set for type 1 diabetes. Compute the average embedding for this set, then calculate the cosine similarity between this reference vector and each individual target embedding. Finally, if one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['EIF5A2', 'ZNF470', 'ADRA2A', 'TMEM8B', 'PHKB']",type 1 diabetes mellitus,unknown,ADRA2A,"Which gene among EIF5A2, ZNF470, ADRA2A, TMEM8B, and PHKB demonstrates the highest degree of cell-type specificity, making it the most promising candidate for therapeutic targeting in type 1 diabetes mellitus?","Which gene among EIF5A2, ZNF470, ADRA2A, TMEM8B, and PHKB demonstrates the highest degree of cell-type specificity, making it the most promising candidate for therapeutic targeting in type 1 diabetes mellitus? Identify all verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which unknown-activated genes in PINNACLE overlap with these targets to define cell-type–specific targets for the disease. Calculate the average embedding of these targets, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation of its biological relevance."
"['PHF7', 'MEA1', 'TTC21B', 'PRR34-AS1', 'IQSEC1']",type 1 diabetes mellitus,unknown,TTC21B,"Which gene among PHF7, MEA1, TTC21B, PRR34-AS1, and IQSEC1 exhibits the highest degree of cell-type–specific expression, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among PHF7, MEA1, TTC21B, PRR34-AS1, and IQSEC1 exhibits the highest degree of cell-type–specific expression, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which unknown activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OR7C1', 'PDGFRB', 'CBLL1', 'TMC5', 'POLI']",type 1 diabetes mellitus,unknown,PDGFRB,"Which gene among OR7C1, PDGFRB, CBLL1, TMC5, and POLI exhibits the most restricted, cell-type–specific expression in tissues relevant to type 1 diabetes mellitus?","Which gene among OR7C1, PDGFRB, CBLL1, TMC5, and POLI exhibits the most restricted, cell-type–specific expression in tissues relevant to type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which unknown activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for these overlapping targets as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SYF2', 'IFT46', 'TSPAN18', 'ATAD1', 'BRD9']",type 1 diabetes mellitus,unknown,ATAD1,"Which gene from the set (SYF2, IFT46, TSPAN18, ATAD1, BRD9) exhibits the highest cell-type specificity and could serve as the most promising candidate for targeting in type 1 diabetes mellitus?","Which gene from the set (SYF2, IFT46, TSPAN18, ATAD1, BRD9) exhibits the highest cell-type specificity and could serve as the most promising candidate for targeting in type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify which unknown-activated genes from PINNACLE overlap with these targets to establish a cell-type–specific target set. Calculate the average embedding of this set and then determine the cosine similarity between this reference embedding and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KBTBD11', 'SLC25A44', 'NOCT', 'SHOC1', 'JAZF1']",type 1 diabetes mellitus,unknown,JAZF1,"Among the genes KBTBD11, SLC25A44, NOCT, SHOC1, and JAZF1, which shows the most cell-type-specific expression that could be relevant for targeted interventions in type 1 diabetes mellitus?","Among the genes KBTBD11, SLC25A44, NOCT, SHOC1, and JAZF1, which shows the most cell-type-specific expression that could be relevant for targeted interventions in type 1 diabetes mellitus? Using PINNACLE, identify the verified therapeutic targets for type 1 diabetes mellitus by retrieving their cell-type–specific embeddings. Next, determine the overlap between these targets and the unknown activated genes recorded in PINNACLE to generate a set of cell-type–specific targets. Compute the average embedding for this set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM121B', 'EIF5A', 'RHOF', 'USP21', 'LINC01798']",type 1 diabetes mellitus,unknown,EIF5A,"Which gene among TMEM121B, EIF5A, RHOF, USP21, and LINC01798 exhibits the most pronounced cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, thereby representing the best candidate for targeted therapeutic research?","Which gene among TMEM121B, EIF5A, RHOF, USP21, and LINC01798 exhibits the most pronounced cell-type-specific expression in tissues relevant to type 1 diabetes mellitus, thereby representing the best candidate for targeted therapeutic research? Identify verified therapeutic target genes for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the unknown-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SCAF11', 'GOLGA6L4', 'LINC00570', 'ARHGEF25', 'CAGE1']",type 1 diabetes mellitus,unknown,SCAF11,"Which gene among SCAF11, GOLGA6L4, LINC00570, ARHGEF25, and CAGE1 shows the highest cell-type specificity and thus represents the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among SCAF11, GOLGA6L4, LINC00570, ARHGEF25, and CAGE1 shows the highest cell-type specificity and thus represents the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Determine which of the unknown-activated genes in PINNACLE overlap with these targets, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this reference embedding and that of each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NEURL1B', 'FUT8', 'CHCHD6', 'ATXN7L3B', 'GLYCTK']",type 1 diabetes mellitus,unknown,ATXN7L3B,"Which gene—NEURL1B, FUT8, CHCHD6, ATXN7L3B, or GLYCTK—exhibits the most cell-type specific expression and could represent the best candidate for targeted therapy in type 1 diabetes mellitus?","Which gene—NEURL1B, FUT8, CHCHD6, ATXN7L3B, or GLYCTK—exhibits the most cell-type specific expression and could represent the best candidate for targeted therapy in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the PINNACLE-activated genes overlap with these targets to define a set of cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this average embedding and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HDLBP', 'TM2D2', 'LINC01805', 'SH2D4B', 'ZC3H8']",type 1 diabetes mellitus,pancreatic a cell,HDLBP,"Among the genes HDLBP, TM2D2, LINC01805, SH2D4B, and ZC3H8, which one exhibits the highest specificity for pancreatic alpha cells, thereby representing the optimal candidate for targeted therapy in type 1 diabetes mellitus?","Among the genes HDLBP, TM2D2, LINC01805, SH2D4B, and ZC3H8, which one exhibits the highest specificity for pancreatic alpha cells, thereby representing the optimal candidate for targeted therapy in type 1 diabetes mellitus? Retrieve the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Identify which of these targets overlap with pancreatic α cell–activated genes in PINNACLE. Using the overlapping set, compute the average embedding to serve as a reference, and then determine the cosine similarity between this reference and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence‐based rationale for its biological relevance."
"['FAM186B', 'FAP', 'KEL', 'SLC35E1', 'LINC00467']",type 1 diabetes mellitus,pancreatic a cell,FAP,"Among the genes FAM186B, FAP, KEL, SLC35E1, and LINC00467, which one demonstrates the highest cell-type specificity in pancreatic alpha cells, making it the optimal candidate for targeting type 1 diabetes mellitus?","Among the genes FAM186B, FAP, KEL, SLC35E1, and LINC00467, which one demonstrates the highest cell-type specificity in pancreatic alpha cells, making it the optimal candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings using PINNACLE. Next, determine which of these targets overlap with the gene set activated in pancreatic α cells in PINNACLE. Calculate the average embedding for the overlapping genes to serve as a reference, then compute the cosine similarity for each individual target relative to this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FZD2', 'YIPF6', 'SLC25A2', 'KLF3', 'CCAR1']",type 1 diabetes mellitus,pancreatic a cell,KLF3,"Which gene from the set {FZD2, YIPF6, SLC25A2, KLF3, CCAR1} exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene from the set {FZD2, YIPF6, SLC25A2, KLF3, CCAR1} exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in pancreatic α cells. Compute the average embedding of the overlapping genes, and then calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FMO2', 'CTDNEP1', 'CAV2', 'OSBPL2', 'LINC01954']",type 1 diabetes mellitus,pancreatic a cell,CTDNEP1,"Which gene among FMO2, CTDNEP1, CAV2, OSBPL2, and LINC01954 exhibits the highest specificity for pancreatic alpha cells, making it a promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among FMO2, CTDNEP1, CAV2, OSBPL2, and LINC01954 exhibits the highest specificity for pancreatic alpha cells, making it a promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic α cell-activated genes within PINNACLE. For the overlapping genes, compute the average embedding vector, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['REM2', 'DENND2B', 'BUB1B', 'DGCR8', 'HIPK1']",type 1 diabetes mellitus,pancreatic a cell,HIPK1,"Among the genes REM2, DENND2B, BUB1B, DGCR8, and HIPK1, which exhibits the highest expression specificity in pancreatic α cells for a targeted approach to type 1 diabetes mellitus?","Among the genes REM2, DENND2B, BUB1B, DGCR8, and HIPK1, which exhibits the highest expression specificity in pancreatic α cells for a targeted approach to type 1 diabetes mellitus? Identify all validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic alpha cell-activated genes in PINNACLE overlap with these targets, thereby defining cell-type–specific candidate targets. Calculate the average embedding of these candidates, then assess the cosine similarity between this average and each individual candidate's embedding. If a single gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LSMEM2', 'ZNF138', 'CRYBB1', 'AGO1', 'ZNF133']",type 1 diabetes mellitus,pancreatic a cell,AGO1,"Which gene—LSMEM2, ZNF138, CRYBB1, AGO1, or ZNF133—exhibits the highest specificity for pancreatic alpha cells, making it the most promising candidate for targeting in type 1 diabetes mellitus?","Which gene—LSMEM2, ZNF138, CRYBB1, AGO1, or ZNF133—exhibits the highest specificity for pancreatic alpha cells, making it the most promising candidate for targeting in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and genes activated in pancreatic alpha cells. Compute the average embedding of this overlapping gene set and calculate the cosine similarity between this reference and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LDOC1', 'NPHP3', 'SEPTIN2', 'NFIA-AS2', 'KCNQ5']",type 1 diabetes mellitus,pancreatic a cell,SEPTIN2,"Which gene among LDOC1, NPHP3, SEPTIN2, NFIA-AS2, and KCNQ5 shows the highest cell-type–specific expression in pancreatic α-cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus?","Which gene among LDOC1, NPHP3, SEPTIN2, NFIA-AS2, and KCNQ5 shows the highest cell-type–specific expression in pancreatic α-cells, making it the most promising candidate for targeted interventions in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell type–specific embeddings from PINNACLE. Next, identify the pancreatic α cell–activated genes in PINNACLE that overlap with these targets to define a set of cell type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set to serve as a reference, and calculate the cosine similarity between this reference and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFV2', 'APOBEC3C', 'NCBP2L', 'DENND2B', 'KPTN']",type 1 diabetes mellitus,pancreatic a cell,NDUFV2,"Which gene among NDUFV2, APOBEC3C, NCBP2L, DENND2B, and KPTN exhibits the highest degree of specificity in pancreatic alpha cells relevant to type 1 diabetes mellitus?","Which gene among NDUFV2, APOBEC3C, NCBP2L, DENND2B, and KPTN exhibits the highest degree of specificity in pancreatic alpha cells relevant to type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the pancreatic alpha cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for the disease. Compute the average embedding for these overlapping targets, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PHF5A', 'CDKN1C', 'ZPBP', 'IL1RAPL1', 'GBP6']",type 1 diabetes mellitus,pancreatic a cell,CDKN1C,"Which gene, among PHF5A, CDKN1C, ZPBP, IL1RAPL1, and GBP6, demonstrates the highest cell-type specificity in pancreatic alpha cells for targeting type 1 diabetes mellitus?","Which gene, among PHF5A, CDKN1C, ZPBP, IL1RAPL1, and GBP6, demonstrates the highest cell-type specificity in pancreatic alpha cells for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in pancreatic alpha cells as recorded in PINNACLE, and compute the average embedding of this overlapping set. Calculate the cosine similarity between each individual target's embedding and the average embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['B4GAT1', 'MRM3', 'LINC02385', 'LINC00261', 'GSN']",type 1 diabetes mellitus,pancreatic a cell,GSN,"Which gene among B4GAT1, MRM3, LINC02385, LINC00261, and GSN exhibits the highest cell-type specificity in pancreatic alpha cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among B4GAT1, MRM3, LINC02385, LINC00261, and GSN exhibits the highest cell-type specificity in pancreatic alpha cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic alpha cell-activated genes overlap with these targets and compute their average embedding as a reference. Calculate the cosine similarity between this reference and the embedding of each target gene. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABCD1', 'ASAP1', 'CSNKA2IP', 'C14orf39', 'CEP128']",type 1 diabetes mellitus,pancreatic a cell,ASAP1,"Among the genes ABCD1, ASAP1, CSNKA2IP, C14orf39, and CEP128, which exhibits the highest specificity for pancreatic α-cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes ABCD1, ASAP1, CSNKA2IP, C14orf39, and CEP128, which exhibits the highest specificity for pancreatic α-cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in pancreatic alpha cells within PINNACLE, as this overlap represents type 1 diabetes cell–specific targets. Calculate the average embedding of the overlapping genes, then compute the cosine similarity between this average and each individual target's embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological significance."
"['SRGAP2', 'GEMIN4', 'PACS1', 'EIF3K', 'ASCL2']",type 1 diabetes mellitus,pancreatic a cell,ASCL2,"Among the genes SRGAP2, GEMIN4, PACS1, EIF3K, and ASCL2, which shows the greatest specificity for pancreatic α cells in the context of targeting type 1 diabetes mellitus?","Among the genes SRGAP2, GEMIN4, PACS1, EIF3K, and ASCL2, which shows the greatest specificity for pancreatic α cells in the context of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with pancreatic alpha cell–activated genes in PINNACLE, defining the cell-type-specific targets for T1D. Compute the average embedding of this overlapping set, then calculate the cosine similarity between that average and each individual target embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GOLGA8M_ENSG00000188626', 'EEF1AKMT1', 'ODC1', 'ZNF454', 'SNX4']",type 1 diabetes mellitus,pancreatic a cell,ODC1,"Which gene among GOLGA8M_ENSG00000188626, EEF1AKMT1, ODC1, ZNF454, and SNX4 exhibits the most specific expression in pancreatic alpha cells, making it the most promising candidate for targeting in type 1 diabetes mellitus therapies?","Which gene among GOLGA8M_ENSG00000188626, EEF1AKMT1, ODC1, ZNF454, and SNX4 exhibits the most specific expression in pancreatic alpha cells, making it the most promising candidate for targeting in type 1 diabetes mellitus therapies? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the pancreatic α cell–activated genes in PINNACLE to establish a set of cell-type–specific targets. Compute the average embedding of these overlapping targets and then calculate the cosine similarity between this reference and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TTC1', 'SP2', 'HBP1', 'LINC01451', 'TNIK']",type 1 diabetes mellitus,pancreatic a cell,HBP1,"Which gene among TTC1, SP2, HBP1, LINC01451, and TNIK exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among TTC1, SP2, HBP1, LINC01451, and TNIK exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pancreatic alpha cell-activated genes represented in PINNACLE. Compute the average embedding of the overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AEBP2', 'RSPH10B2', 'TRAF7', 'PPA1', 'RSBN1']",type 1 diabetes mellitus,pancreatic a cell,RSBN1,"Among AEBP2, RSPH10B2, TRAF7, PPA1, and RSBN1, which gene exhibits the highest cell-type specificity in pancreatic α cells for targeting type 1 diabetes mellitus?","Among AEBP2, RSPH10B2, TRAF7, PPA1, and RSBN1, which gene exhibits the highest cell-type specificity in pancreatic α cells for targeting type 1 diabetes mellitus? Which validated therapeutic targets for type 1 diabetes mellitus are represented in PINNACLE, and what are their cell-type–specific embeddings? Among the genes activated in pancreatic α cells in PINNACLE, which overlap with these targets? Using the overlapping set, calculate an average embedding to serve as a reference, then compute the cosine similarity between this reference and each individual target. Identify the gene with a markedly higher similarity than the others, and provide a concise, evidence-based rationale for its biological relevance in type 1 diabetes mellitus."
"['ITGB4', 'PTEN', 'PDXP-DT', 'DEPDC1', 'SPRY1']",type 1 diabetes mellitus,pancreatic a cell,PTEN,"Among the following genes—ITGB4, PTEN, PDXP-DT, DEPDC1, and SPRY1—which one exhibits the highest cell-type specificity in pancreatic cells, making it the most promising candidate for targeted type 1 diabetes mellitus therapy?","Among the following genes—ITGB4, PTEN, PDXP-DT, DEPDC1, and SPRY1—which one exhibits the highest cell-type specificity in pancreatic cells, making it the most promising candidate for targeted type 1 diabetes mellitus therapy? Retrieve the validated therapeutic targets for type 1 diabetes mellitus by obtaining their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping genes between these targets and the pancreatic alpha cell–activated genes in PINNACLE to define the cell-type–specific targets for the disease. Compute the average embedding of this subset and determine the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OOSP3', 'PEX11A', 'SH2D7', 'SPIRE1', 'MAIP1']",type 1 diabetes mellitus,pancreatic a cell,SPIRE1,"Among the genes OOSP3, PEX11A, SH2D7, SPIRE1, and MAIP1, which exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes OOSP3, PEX11A, SH2D7, SPIRE1, and MAIP1, which exhibits the highest cell-type specificity in pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Determine which of these targets overlap with genes activated in pancreatic α cells. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NDUFB5', 'PXMP2', 'ITGA1', 'CLEC19A', 'ZBTB44']",type 1 diabetes mellitus,pancreatic a cell,NDUFB5,"Among the genes NDUFB5, PXMP2, ITGA1, CLEC19A, and ZBTB44, which one exhibits the highest specificity of expression in pancreatic α cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes NDUFB5, PXMP2, ITGA1, CLEC19A, and ZBTB44, which one exhibits the highest specificity of expression in pancreatic α cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic alpha cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Compute the average embedding for these targets and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM51', 'C6orf136', 'PRSS8', 'PCDHA12', 'VPS13D']",type 1 diabetes mellitus,pancreatic a cell,C6orf136,"Which gene among TMEM51, C6orf136, PRSS8, PCDHA12, and VPS13D shows the highest specificity for pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among TMEM51, C6orf136, PRSS8, PCDHA12, and VPS13D shows the highest specificity for pancreatic alpha cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic alpha cells within PINNACLE, thereby defining the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PGR', 'KRT27', 'FAM81A', 'PCBD1', 'FRMPD4']",type 1 diabetes mellitus,pancreatic a cell,PGR,"Which gene among PGR, KRT27, FAM81A, PCBD1, and FRMPD4 exhibits the highest cell-type specificity in pancreatic alpha cells for potential therapeutic targeting of type 1 diabetes mellitus?","Which gene among PGR, KRT27, FAM81A, PCBD1, and FRMPD4 exhibits the highest cell-type specificity in pancreatic alpha cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the genes activated in pancreatic alpha cells. Compute the average embedding of the overlapping set and calculate the cosine similarity between this reference vector and the embedding of each target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['MANCR', 'PTRHD1', 'SS18L1', 'LINC01522', 'ZNF713']",type 1 diabetes mellitus,pancreatic stellate cell,PTRHD1,"Which gene among MANCR, PTRHD1, SS18L1, LINC01522, and ZNF713 shows the highest cell-type specificity in pancreatic stellate cells associated with type 1 diabetes mellitus?","Which gene among MANCR, PTRHD1, SS18L1, LINC01522, and ZNF713 shows the highest cell-type specificity in pancreatic stellate cells associated with type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in pancreatic stellate cells as recorded in PINNACLE. Using this overlapping set, calculate an average embedding and compute the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TAPT1', 'PHLDA2', 'COPB1', 'MYO5A', 'CDK5RAP3']",type 1 diabetes mellitus,pancreatic stellate cell,CDK5RAP3,"Among TAPT1, PHLDA2, COPB1, MYO5A, and CDK5RAP3, which gene displays the greatest cell-type specificity in pancreatic stellate cells relevant for therapeutic intervention in type 1 diabetes mellitus?","Among TAPT1, PHLDA2, COPB1, MYO5A, and CDK5RAP3, which gene displays the greatest cell-type specificity in pancreatic stellate cells relevant for therapeutic intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus from the PINNACLE dataset and extract their cell-type–specific embeddings. Next, determine which genes activated in pancreatic stellate cells (as defined in PINNACLE) overlap with these targets, thereby defining a set of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IL1R1', 'CDAN1', 'DHCR24', 'EME2', 'CAMTA1']",type 1 diabetes mellitus,pancreatic stellate cell,IL1R1,"Which gene among IL1R1, CDAN1, DHCR24, EME2, and CAMTA1 exhibits the highest cell-type specificity in pancreatic stellate cells, making it the optimal candidate for targeting type 1 diabetes mellitus?","Which gene among IL1R1, CDAN1, DHCR24, EME2, and CAMTA1 exhibits the highest cell-type specificity in pancreatic stellate cells, making it the optimal candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, identify the subset of these targets that overlap with pancreatic stellate cell-activated genes in PINNACLE. Using this overlapping set, calculate the average embedding as a reference and determine the cosine similarity between this reference and each individual target. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PLBD2', 'LINC02251', 'NSL1', 'TRIM17', 'IGDCC3']",type 1 diabetes mellitus,pancreatic stellate cell,NSL1,"Among the genes PLBD2, LINC02251, NSL1, TRIM17, and IGDCC3, which one demonstrates the highest cell-type specificity in pancreatic stellate cells for potential therapeutic targeting of type 1 diabetes mellitus?","Among the genes PLBD2, LINC02251, NSL1, TRIM17, and IGDCC3, which one demonstrates the highest cell-type specificity in pancreatic stellate cells for potential therapeutic targeting of type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Then, determine which genes activated in pancreatic stellate cells within PINNACLE overlap with these targets to define the set of cell-type–specific T1DM targets. Compute the average embedding for this overlapping set, and assess the cosine similarity between this average and the embedding of each individual target. If one gene shows significantly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological significance."
"['TPGS1', 'ZNF385D', 'ARIH1', 'ZNF107', 'PHYHIP']",type 1 diabetes mellitus,pancreatic stellate cell,TPGS1,"Which gene among TPGS1, ZNF385D, ARIH1, ZNF107, and PHYHIP exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among TPGS1, ZNF385D, ARIH1, ZNF107, and PHYHIP exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Using PINNACLE, retrieve the cell-type–specific embeddings for verified therapeutic targets associated with type 1 diabetes mellitus. Identify which of these targets overlap with the set of pancreatic stellate cell-activated genes in PINNACLE. Compute the average embedding for the overlapping targets as a reference and calculate the cosine similarity between this reference and each individual target’s embedding. Determine if one gene exhibits a markedly higher similarity relative to the others, and if so, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['LINC02817', 'KIFC2', 'S100A5', 'UBTF', 'SKAP2']",type 1 diabetes mellitus,pancreatic stellate cell,SKAP2,"Among LINC02817, KIFC2, S100A5, UBTF, and SKAP2, which gene exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Among LINC02817, KIFC2, S100A5, UBTF, and SKAP2, which gene exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic stellate cell–activated genes in PINNACLE, forming a set of cell-type–specific targets. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this reference embedding and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UNC13C', 'PSMC5', 'FAM181A-AS1', 'GRID2', 'INSR']",type 1 diabetes mellitus,pancreatic stellate cell,INSR,"Which gene among UNC13C, PSMC5, FAM181A-AS1, GRID2, and INSR exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among UNC13C, PSMC5, FAM181A-AS1, GRID2, and INSR exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are among the pancreatic stellate cell-activated genes in PINNACLE. Compute the average embedding of the overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['E2F5', 'ANKH', 'LINC02632', 'MT-ND4L', 'LINC01704']",type 1 diabetes mellitus,pancreatic stellate cell,MT-ND4L,"Among the following genes—E2F5, ANKH, LINC02632, MT-ND4L, and LINC01704—which one exhibits the highest cell-type specificity in pancreatic stellate cells as the most promising candidate target for type 1 diabetes mellitus?","Among the following genes—E2F5, ANKH, LINC02632, MT-ND4L, and LINC01704—which one exhibits the highest cell-type specificity in pancreatic stellate cells as the most promising candidate target for type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific PINNACLE embeddings. Next, determine the overlap between these targets and the genes activated in pancreatic stellate cells from PINNACLE. Compute the average embedding of the overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARL17B', 'NFKBIB', 'VIL1', 'DUS3L', 'FADS2']",type 1 diabetes mellitus,pancreatic stellate cell,FADS2,"Among the genes ARL17B, NFKBIB, VIL1, DUS3L, and FADS2, which one displays the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes ARL17B, NFKBIB, VIL1, DUS3L, and FADS2, which one displays the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the pancreatic stellate cell–activated gene set in PINNACLE to define the cell-type–specific targets for the disease. Compute the average embedding of these overlapping targets, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPL32', 'NDUFA11', 'MPP7-DT', 'BOD1L1', 'DENND5A']",type 1 diabetes mellitus,pancreatic stellate cell,NDUFA11,"Which gene among RPL32, NDUFA11, MPP7-DT, BOD1L1, and DENND5A exhibits the highest cell-type specific expression in pancreatic stellate cells as a potential target for type 1 diabetes mellitus?","Which gene among RPL32, NDUFA11, MPP7-DT, BOD1L1, and DENND5A exhibits the highest cell-type specific expression in pancreatic stellate cells as a potential target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the pancreatic stellate cell–activated genes in PINNACLE to obtain a set of cell-type–specific targets. Calculate the average embedding for these targets and compute the cosine similarity between this average and each individual target embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PCDHGA2', 'SAFB2', 'PCSK1N', 'SH2B3', 'CLN8']",type 1 diabetes mellitus,pancreatic stellate cell,SH2B3,"Among the genes PCDHGA2, SAFB2, PCSK1N, SH2B3, and CLN8, which exhibits the highest cell-type specificity in pancreatic stellate cells for potential targeting in type 1 diabetes mellitus?","Among the genes PCDHGA2, SAFB2, PCSK1N, SH2B3, and CLN8, which exhibits the highest cell-type specificity in pancreatic stellate cells for potential targeting in type 1 diabetes mellitus? Using verified therapeutic targets for type 1 diabetes mellitus and their cell-type–specific embeddings from PINNACLE, identify the genes that overlap with those activated in pancreatic stellate cells. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDE7A-DT', 'FALEC', 'KANTR', 'SEPTIN9-DT', 'TAPBP']",type 1 diabetes mellitus,pancreatic stellate cell,TAPBP,"Which gene among PDE7A-DT, FALEC, KANTR, SEPTIN9-DT, and TAPBP exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among PDE7A-DT, FALEC, KANTR, SEPTIN9-DT, and TAPBP exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with pancreatic stellate cell-activated genes in PINNACLE. Compute the average embedding of the overlapping gene set as a reference, and then calculate the cosine similarity between this reference and the embedding of each target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based explanation of its biological relevance."
"['F2R', 'FAM13C', 'UBE2D4', 'IPO4', 'SET']",type 1 diabetes mellitus,pancreatic stellate cell,F2R,"Among F2R, FAM13C, UBE2D4, IPO4, and SET, which gene exhibits the highest cell-type specificity in pancreatic stellate cells in the context of type 1 diabetes mellitus?","Among F2R, FAM13C, UBE2D4, IPO4, and SET, which gene exhibits the highest cell-type specificity in pancreatic stellate cells in the context of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with pancreatic stellate cell–activated genes in PINNACLE, forming the cell-type–specific target set. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RIMKLA', 'LARP4B', 'CATSPER3', 'ATF6B', 'MOGAT3']",type 1 diabetes mellitus,pancreatic stellate cell,ATF6B,"Which gene among RIMKLA, LARP4B, CATSPER3, ATF6B, and MOGAT3 exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among RIMKLA, LARP4B, CATSPER3, ATF6B, and MOGAT3 exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the confirmed therapeutic targets for type 1 diabetes mellitus in PINNACLE and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with the genes activated in pancreatic stellate cells. Compute the average embedding of the overlapping genes as a reference and calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PARD3', 'WDR45B', 'LTBP1', 'KAT5', 'TP73-AS2']",type 1 diabetes mellitus,pancreatic stellate cell,LTBP1,"Which gene—PARD3, WDR45B, LTBP1, KAT5, or TP73-AS2—exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising target for therapeutic intervention in type 1 diabetes mellitus?","Which gene—PARD3, WDR45B, LTBP1, KAT5, or TP73-AS2—exhibits the highest cell-type specificity in pancreatic stellate cells, making it the most promising target for therapeutic intervention in type 1 diabetes mellitus? Identify the established therapeutic targets for type 1 diabetes mellitus and obtain their cell-type specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in pancreatic stellate cells as defined by PINNACLE, thereby defining the cell-type specific targets for this disease. Compute the average embedding of the overlapping targets and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPC6', 'TANGO6', 'ZNF467', 'CDKL4', 'PLXNA2']",type 1 diabetes mellitus,pancreatic stellate cell,GPC6,"Which gene among GPC6, TANGO6, ZNF467, CDKL4, and PLXNA2 exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus?","Which gene among GPC6, TANGO6, ZNF467, CDKL4, and PLXNA2 exhibits the highest cell-type specificity in pancreatic stellate cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the genes activated in pancreatic stellate cells as listed in PINNACLE. Calculate the average embedding of this overlapping gene set and compute the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PWRN1', 'LINC01668', 'NDUFA7', 'FXN', 'LRRD1']",type 1 diabetes mellitus,pancreatic stellate cell,NDUFA7,"Which gene among PWRN1, LINC01668, NDUFA7, FXN, and LRRD1 shows the most cell-type-specific expression in pancreatic stellate cells, thereby representing the best candidate for targeting type 1 diabetes mellitus?","Which gene among PWRN1, LINC01668, NDUFA7, FXN, and LRRD1 shows the most cell-type-specific expression in pancreatic stellate cells, thereby representing the best candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the gene set activated in pancreatic stellate cells as recorded in PINNACLE. Calculate the average embedding for the overlapping targets and compute the cosine similarity between this reference and each individual target. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['MAPK4', 'ZNF836', 'ALDH2', 'FOXL2', 'TSNARE1']",type 1 diabetes mellitus,pancreatic stellate cell,ALDH2,"Among the candidate genes MAPK4, ZNF836, ALDH2, FOXL2, and TSNARE1, which one exhibits the highest cell-type specificity in pancreatic stellate cells, suggesting its potential as a targeted therapy for type 1 diabetes mellitus?","Among the candidate genes MAPK4, ZNF836, ALDH2, FOXL2, and TSNARE1, which one exhibits the highest cell-type specificity in pancreatic stellate cells, suggesting its potential as a targeted therapy for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their corresponding cell-type-specific embeddings from PINNACLE. Next, determine which of these targets are among the pancreatic stellate cell–activated genes in PINNACLE; define this intersection as the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this set as a reference, then calculate the cosine similarity between this reference and the individual target embeddings. If one gene consistently exhibits a markedly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PTGS2', 'KRTCAP3', 'ARHGAP5', 'EVA1A', 'GTPBP3']",type 1 diabetes mellitus,pancreatic stellate cell,PTGS2,"Among the candidate genes PTGS2, KRTCAP3, ARHGAP5, EVA1A, and GTPBP3, which one exhibits the greatest specificity for pancreatic stellate cells as a potential therapeutic target for type 1 diabetes mellitus?","Among the candidate genes PTGS2, KRTCAP3, ARHGAP5, EVA1A, and GTPBP3, which one exhibits the greatest specificity for pancreatic stellate cells as a potential therapeutic target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic stellate cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. Finally, if one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC30A3', 'CTDNEP1', 'FHL1', 'SEC61A2', 'E2F8']",type 1 diabetes mellitus,pancreatic stellate cell,CTDNEP1,"Among the genes SLC30A3, CTDNEP1, FHL1, SEC61A2, and E2F8, which exhibits the highest specificity for pancreatic stellate cells as a target for type 1 diabetes mellitus?","Among the genes SLC30A3, CTDNEP1, FHL1, SEC61A2, and E2F8, which exhibits the highest specificity for pancreatic stellate cells as a target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic stellate cell-activated genes in PINNACLE, as this intersection represents the cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target gene. If one gene exhibits markedly higher similarity compared to the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IRF2', 'BANF2', 'HEY1', 'SEC11C', 'LDLRAD3']",type 1 diabetes mellitus,pancreatic acinar cell,IRF2,"Among IRF2, BANF2, HEY1, SEC11C, and LDLRAD3, which gene demonstrates the highest cell-type specificity in pancreatic acinar cells and is most promising as a therapeutic target for type 1 diabetes mellitus?","Among IRF2, BANF2, HEY1, SEC11C, and LDLRAD3, which gene demonstrates the highest cell-type specificity in pancreatic acinar cells and is most promising as a therapeutic target for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic acinar cell–activated genes in PINNACLE overlap with these targets to define the acinar cell–specific targets for type 1 diabetes. Compute the average embedding for these genes and calculate the cosine similarity between this reference and each individual target. Finally, if one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['VSIG8', 'LINC02026', 'MANEA-DT', 'FBXW2', 'PRDX5']",type 1 diabetes mellitus,pancreatic acinar cell,PRDX5,"Among the genes VSIG8, LINC02026, MANEA-DT, FBXW2, and PRDX5, which exhibits the greatest cell-type specificity in pancreatic acinar cells as a potential target for type 1 diabetes mellitus?","Among the genes VSIG8, LINC02026, MANEA-DT, FBXW2, and PRDX5, which exhibits the greatest cell-type specificity in pancreatic acinar cells as a potential target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes and retrieve their cell-type-specific embedding vectors from PINNACLE. Then, determine which of these targets overlap with the pancreatic acinar cell-activated genes in PINNACLE. For the overlapping genes, compute the average embedding vector as a reference and calculate the cosine similarity between this reference and each individual gene's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SUOX', 'C11orf87', 'ROPN1L-AS1', 'PLD5', 'RAB33B-AS1']",type 1 diabetes mellitus,pancreatic acinar cell,SUOX,"Among the following candidates—SUOX, C11orf87, ROPN1L-AS1, PLD5, and RAB33B-AS1—which gene exhibits the highest specificity for pancreatic acinar cells, making it a potential target for type 1 diabetes mellitus intervention?","Among the following candidates—SUOX, C11orf87, ROPN1L-AS1, PLD5, and RAB33B-AS1—which gene exhibits the highest specificity for pancreatic acinar cells, making it a potential target for type 1 diabetes mellitus intervention? Retrieve the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the pancreatic acinar cell–activated genes catalogued in PINNACLE, as this overlapping set represents the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TARDBP', 'TRIM62', 'BBS9', 'EIF3C', 'LMBRD1']",type 1 diabetes mellitus,pancreatic acinar cell,EIF3C,"Among the genes TARDBP, TRIM62, BBS9, EIF3C, and LMBRD1, which one exhibits the most specific expression in pancreatic acinar cells and may serve as a targeted candidate for type 1 diabetes mellitus intervention?","Among the genes TARDBP, TRIM62, BBS9, EIF3C, and LMBRD1, which one exhibits the most specific expression in pancreatic acinar cells and may serve as a targeted candidate for type 1 diabetes mellitus intervention? Identify clinically validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type specific embeddings from PINNACLE. Next, determine which of these targets overlap with pancreatic acinar cell-activated genes from PINNACLE. Using this overlapping set, compute their average embedding as a reference, then calculate the cosine similarity between this reference and each target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DNAAF6', 'RHEBL1', 'PDE6G', 'MARCHF5', 'CFI']",type 1 diabetes mellitus,pancreatic acinar cell,MARCHF5,"Which gene among DNAAF6, RHEBL1, PDE6G, MARCHF5, and CFI exhibits the highest specificity for expression in pancreatic acinar cells relevant to targeting type 1 diabetes mellitus?","Which gene among DNAAF6, RHEBL1, PDE6G, MARCHF5, and CFI exhibits the highest specificity for expression in pancreatic acinar cells relevant to targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus using their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in pancreatic acinar cells to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly greater similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SNRNP48', 'PPP2R3A', 'PDSS2', 'HAS2', 'PPA2']",type 1 diabetes mellitus,pancreatic acinar cell,PPP2R3A,"Which gene—SNRNP48, PPP2R3A, PDSS2, HAS2, or PPA2—demonstrates the highest specificity within pancreatic acinar cells for potential targeting in type 1 diabetes mellitus?","Which gene—SNRNP48, PPP2R3A, PDSS2, HAS2, or PPA2—demonstrates the highest specificity within pancreatic acinar cells for potential targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic acinar cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for the disease. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01991', 'PGM1', 'SETD9', 'GPR68', 'CALR3']",type 1 diabetes mellitus,pancreatic acinar cell,PGM1,"Among the genes LINC01991, PGM1, SETD9, GPR68, and CALR3, which exhibits the highest cell-type specificity in pancreatic acinar cells relevant to targeting type 1 diabetes mellitus?","Among the genes LINC01991, PGM1, SETD9, GPR68, and CALR3, which exhibits the highest cell-type specificity in pancreatic acinar cells relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pancreatic acinar cell-activated genes in PINNACLE intersect with these targets to define cell-type–specific targets for type 1 diabetes. Compute the average embedding of these overlapping genes as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, designate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABTB2', 'PAM16', 'NRARP', 'SLC25A43', 'NDUFB1']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFB1,"Which gene among ABTB2, PAM16, NRARP, SLC25A43, and NDUFB1 exhibits the highest specificity of expression in pancreatic acinar cells for potential targeting in type 1 diabetes mellitus?","Which gene among ABTB2, PAM16, NRARP, SLC25A43, and NDUFB1 exhibits the highest specificity of expression in pancreatic acinar cells for potential targeting in type 1 diabetes mellitus? Using the PINNACLE database, first identify validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings. Next, determine the intersection between these targets and genes activated in pancreatic acinar cells. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and the individual target embeddings. If one gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in type 1 diabetes mellitus."
"['MCM6', 'ARSG', 'PPFIA1', 'CNPY1', 'ST8SIA5']",type 1 diabetes mellitus,pancreatic acinar cell,ARSG,"Among the genes MCM6, ARSG, PPFIA1, CNPY1, and ST8SIA5, which one exhibits the highest cell-type-specific expression in pancreatic acinar cells, making it the most promising candidate for targeted studies in type 1 diabetes mellitus?","Among the genes MCM6, ARSG, PPFIA1, CNPY1, and ST8SIA5, which one exhibits the highest cell-type-specific expression in pancreatic acinar cells, making it the most promising candidate for targeted studies in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes and extract their cell-type-specific embeddings from PINNACLE. Next, determine which pancreatic acinar cell-activated genes from PINNACLE overlap with these targets. Compute the average embedding for this overlapping gene set and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene shows considerably higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological significance."
"['KDM3A', 'PRMT8', 'PSMD7', 'NUTM2A', 'SF1']",type 1 diabetes mellitus,pancreatic acinar cell,PSMD7,"Which gene among KDM3A, PRMT8, PSMD7, NUTM2A, and SF1 exhibits the highest cell-type specificity in pancreatic acinar cells as a potential target in type 1 diabetes mellitus?","Which gene among KDM3A, PRMT8, PSMD7, NUTM2A, and SF1 exhibits the highest cell-type specificity in pancreatic acinar cells as a potential target in type 1 diabetes mellitus? Identify the known therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic acinar cells (as identified by PINNACLE) overlap with these therapeutic targets; this overlapping set represents the cell-type–specific targets for the disease. Compute the average embedding of these genes as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RELL2', 'NDUFA4', 'TDRD1', 'FAHD2A', 'ZMYND8']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFA4,"Which gene among RELL2, NDUFA4, TDRD1, FAHD2A, and ZMYND8 exhibits the greatest specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among RELL2, NDUFA4, TDRD1, FAHD2A, and ZMYND8 exhibits the greatest specificity in pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and genes activated in pancreatic acinar cells in PINNACLE to define a cell-type–specific target set. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a notably higher similarity compared to others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SLC12A8', 'CYP4F26P', 'AMZ2', 'COPRS', 'NAPB']",type 1 diabetes mellitus,pancreatic acinar cell,AMZ2,"Which gene among SLC12A8, CYP4F26P, AMZ2, COPRS, and NAPB exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus?","Which gene among SLC12A8, CYP4F26P, AMZ2, COPRS, and NAPB exhibits the highest cell-type specificity in pancreatic acinar cells for targeting type 1 diabetes mellitus? Identify all therapeutically validated targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine the intersection between these targets and the genes activated in pancreatic acinar cells from PINNACLE. Calculate the average embedding for this overlapping set and assess the cosine similarity between this average and each individual target’s embedding. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['GTF2F1', 'ZBTB3', 'SHMT2', 'C16orf95-DT', 'BRD2']",type 1 diabetes mellitus,pancreatic acinar cell,BRD2,"Which gene among GTF2F1, ZBTB3, SHMT2, C16orf95-DT, and BRD2 displays the highest specificity of expression in pancreatic acinar cells, thereby making it the most promising candidate target for type 1 diabetes mellitus?","Which gene among GTF2F1, ZBTB3, SHMT2, C16orf95-DT, and BRD2 displays the highest specificity of expression in pancreatic acinar cells, thereby making it the most promising candidate target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic acinar cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding and calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF766', 'SEC31B', 'IPMK', 'TM9SF2', 'ATRN']",type 1 diabetes mellitus,pancreatic acinar cell,TM9SF2,"Among the following genes—ZNF766, SEC31B, IPMK, TM9SF2, and ATRN—which one exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted type 1 diabetes mellitus interventions?","Among the following genes—ZNF766, SEC31B, IPMK, TM9SF2, and ATRN—which one exhibits the highest cell-type specificity in pancreatic acinar cells, making it the most promising candidate for targeted type 1 diabetes mellitus interventions? Identify verified therapeutic targets for type 1 diabetes mellitus using PINNACLE and obtain their cell-type–specific embeddings. Next, determine which pancreatic acinar cell‐activated genes from PINNACLE overlap with these targets, forming a set of cell-type–specific targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average embedding and the embedding for each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['CATSPER1', 'ENTHD1', 'NDUFAB1', 'SPAG16', 'MZB1']",type 1 diabetes mellitus,pancreatic acinar cell,NDUFAB1,"Which gene among CATSPER1, ENTHD1, NDUFAB1, SPAG16, and MZB1 exhibits the highest specificity for pancreatic acinar cells in the context of type 1 diabetes mellitus?","Which gene among CATSPER1, ENTHD1, NDUFAB1, SPAG16, and MZB1 exhibits the highest specificity for pancreatic acinar cells in the context of type 1 diabetes mellitus? Using validated therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type specific embeddings from the PINNACLE database. Identify the genes among these targets that overlap with the pancreatic acinar cell-activated genes in PINNACLE. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between the reference and each individual target’s embedding. If one gene shows significantly higher similarity than the others, nominate it as the primary candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['BCL2L12', 'M6PR', 'ARV1', 'SH2D3A', 'NXN']",type 1 diabetes mellitus,pancreatic acinar cell,M6PR,"Among BCL2L12, M6PR, ARV1, SH2D3A, and NXN, which gene exhibits the highest specificity in pancreatic acinar cells as a potential target for interventions against type 1 diabetes mellitus?","Among BCL2L12, M6PR, ARV1, SH2D3A, and NXN, which gene exhibits the highest specificity in pancreatic acinar cells as a potential target for interventions against type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in pancreatic acinar cells overlap with these targets, designating them as cell-type–specific targets for type 1 diabetes. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a notably higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STRIP2', 'PFKFB3', 'SH3TC1', 'NEMP2', 'NT5C']",type 1 diabetes mellitus,pancreatic acinar cell,PFKFB3,"Which gene among STRIP2, PFKFB3, SH3TC1, NEMP2, and NT5C exhibits the highest specificity for pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among STRIP2, PFKFB3, SH3TC1, NEMP2, and NT5C exhibits the highest specificity for pancreatic acinar cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with genes activated in pancreatic acinar cells according to the PINNACLE dataset. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-supported explanation for its biological relevance."
"['SUCLG2', 'ZNF233', 'PMPCA', 'KPNA2', 'TRNT1']",type 1 diabetes mellitus,pancreatic acinar cell,KPNA2,"Among SUCLG2, ZNF233, PMPCA, KPNA2, and TRNT1, which gene exhibits the highest cell-type specificity in pancreatic acinar cells for the purpose of targeting type 1 diabetes mellitus?","Among SUCLG2, ZNF233, PMPCA, KPNA2, and TRNT1, which gene exhibits the highest cell-type specificity in pancreatic acinar cells for the purpose of targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell‐type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic acinar cell–activated genes in PINNACLE. For the overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target. Identify any single gene with a markedly higher similarity score than the others, and provide a concise, evidence-based explanation of its biological significance as the top candidate."
"['DHTKD1', 'INS', 'ANKRD20A2P', 'OR2AP1', 'PRSS37']",type 1 diabetes mellitus,pancreatic acinar cell,INS,"Among the genes DHTKD1, INS, ANKRD20A2P, OR2AP1, and PRSS37, which shows the highest cell-type specificity in pancreatic acinar cells as a potential therapeutic target for type 1 diabetes mellitus?","Among the genes DHTKD1, INS, ANKRD20A2P, OR2AP1, and PRSS37, which shows the highest cell-type specificity in pancreatic acinar cells as a potential therapeutic target for type 1 diabetes mellitus? Using the validated therapeutic targets for type 1 diabetes mellitus, retrieve their cell type–specific embeddings from PINNACLE. Identify which of these overlap with the genes activated in pancreatic acinar cells in PINNACLE to define the cell‐type–specific targets. Calculate the average embedding for this intersecting group and determine the cosine similarity between this reference and each individual target gene. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate, providing a concise, evidence‐based rationale for its biological relevance."
"['DNAAF3', 'SEPTIN9-DT', 'MT-ND4', 'EFCAB5', 'NME9']",type 1 diabetes mellitus,pancreatic acinar cell,MT-ND4,"Among the genes DNAAF3, SEPTIN9-DT, MT-ND4, EFCAB5, and NME9, which one shows the highest cell-type specificity in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus intervention?","Among the genes DNAAF3, SEPTIN9-DT, MT-ND4, EFCAB5, and NME9, which one shows the highest cell-type specificity in pancreatic acinar cells, making it the most promising target for type 1 diabetes mellitus intervention? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pancreatic acinar cell-activated genes from the same database to form a set of cell-type–specific targets. Calculate the average embedding for these genes and compute the cosine similarity between this reference embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EBLN3P', 'KRT83', 'RTEL1', 'HDLBP', 'ZNF540']",type 1 diabetes mellitus,pp cell,HDLBP,"Which gene among EBLN3P, KRT83, RTEL1, HDLBP, and ZNF540 demonstrates the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus?","Which gene among EBLN3P, KRT83, RTEL1, HDLBP, and ZNF540 demonstrates the highest cell-type specificity in pp cells for targeting type 1 diabetes mellitus? What are the verified therapeutic targets for type 1 diabetes mellitus according to PINNACLE, and what are their cell-type–specific embeddings? Among these targets, which genes overlap with the pp cell-activated genes in PINNACLE? Calculate the average embedding from this overlapping set and compare it to each individual target by computing the cosine similarity. If one gene shows a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based explanation of its biological relevance."
"['C5orf34', 'TSPYL2', 'FKBP15', 'RBP5', 'MTCH1']",type 1 diabetes mellitus,pp cell,MTCH1,"Among the genes C5orf34, TSPYL2, FKBP15, RBP5, and MTCH1, which demonstrates the highest cell-type specificity in pancreatic polypeptide (PP) cells as a potential target for type 1 diabetes mellitus?","Among the genes C5orf34, TSPYL2, FKBP15, RBP5, and MTCH1, which demonstrates the highest cell-type specificity in pancreatic polypeptide (PP) cells as a potential target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which cell-activated genes from PINNACLE overlap with these targets, yielding the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this set and compute the cosine similarity between this averaged embedding and that of each individual target. If one gene demonstrates significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['JAK1', 'ETV4', 'PRKACB-DT', 'GPAM', 'PABPC1L2A']",type 1 diabetes mellitus,pp cell,JAK1,"Which gene among JAK1, ETV4, PRKACB-DT, GPAM, and PABPC1L2A demonstrates the highest cell-type specificity in pp cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among JAK1, ETV4, PRKACB-DT, GPAM, and PABPC1L2A demonstrates the highest cell-type specificity in pp cells, thereby representing the most promising candidate for targeting type 1 diabetes mellitus? Using the curated list of verified therapeutic targets for type 1 diabetes mellitus, retrieve their cell-type–specific embeddings from PINNACLE. Then, identify the overlap between these targets and the pp cell-activated genes in PINNACLE to define the cell-type–specific targets for the disease. Compute the average embedding of these targets and evaluate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['ANKS3', 'TAF10', 'FOXN3', 'NID2', 'FAM66B']",type 1 diabetes mellitus,pp cell,FOXN3,"Which gene among ANKS3, TAF10, FOXN3, NID2, and FAM66B exhibits the highest cell-type specificity in pp cells for potential targeting in type 1 diabetes mellitus?","Which gene among ANKS3, TAF10, FOXN3, NID2, and FAM66B exhibits the highest cell-type specificity in pp cells for potential targeting in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the pp cell-activated genes in PINNACLE to define the cell-type–specific target set. Compute the average embedding of this set and calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCDC32', 'PCCA-DT', 'CCDC86', 'BRAF', 'TRIM52']",type 1 diabetes mellitus,pp cell,BRAF,"Which gene among CCDC32, PCCA-DT, CCDC86, BRAF, and TRIM52 demonstrates the highest cell-type specificity in pp cells as a potential target for type 1 diabetes mellitus?","Which gene among CCDC32, PCCA-DT, CCDC86, BRAF, and TRIM52 demonstrates the highest cell-type specificity in pp cells as a potential target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pp cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding for these overlapping genes as a reference profile, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF235', 'KCNT1', 'CCDC200', 'ZNF652', 'GDE1']",type 1 diabetes mellitus,pp cell,ZNF652,"Which gene among ZNF235, KCNT1, CCDC200, ZNF652, and GDE1 exhibits the highest specificity for pp cells, indicating its potential as the optimal target for type 1 diabetes mellitus?","Which gene among ZNF235, KCNT1, CCDC200, ZNF652, and GDE1 exhibits the highest specificity for pp cells, indicating its potential as the optimal target for type 1 diabetes mellitus? Identify verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which pp cell-activated genes in PINNACLE overlap with these targets to generate a set of cell-type–specific targets for the disease. Compute the average embedding of this set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CEP85', 'ALDH2', 'KCTD16', 'LINC00523', 'EBF2']",type 1 diabetes mellitus,pp cell,ALDH2,"Among CEP85, ALDH2, KCTD16, LINC00523, and EBF2, which gene exhibits the highest specificity for expression in pp cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among CEP85, ALDH2, KCTD16, LINC00523, and EBF2, which gene exhibits the highest specificity for expression in pp cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the pp cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes mellitus. Calculate the average embedding of this overlapping gene set and measure the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DDX11', 'UBXN7', 'TPGS1', 'BOLA1', 'TRDMT1']",type 1 diabetes mellitus,pp cell,TPGS1,"Which gene among DDX11, UBXN7, TPGS1, BOLA1, and TRDMT1 demonstrates the highest cell-type specificity in PP cells for targeted intervention in type 1 diabetes mellitus?","Which gene among DDX11, UBXN7, TPGS1, BOLA1, and TRDMT1 demonstrates the highest cell-type specificity in PP cells for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the pp cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set and determine the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['XRCC1', 'C5orf63', 'PTEN', 'LINC02426', 'C20orf141']",type 1 diabetes mellitus,pp cell,PTEN,"Which gene among XRCC1, C5orf63, PTEN, LINC02426, and C20orf141 exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus?","Which gene among XRCC1, C5orf63, PTEN, LINC02426, and C20orf141 exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus using PINNACLE and retrieve their cell-type–specific embeddings. Next, determine which pp cell-activated genes in PINNACLE overlap with these targets, defining this overlapping set as the cell-type–specific targets. Compute the average embedding of these targets as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and supply a concise, evidence-based rationale for its biological relevance."
"['EPM2A', 'C2orf74', 'SCAF11', 'GAL3ST4', 'PAGE4']",type 1 diabetes mellitus,pp cell,SCAF11,"Which gene among EPM2A', C2orf74, SCAF11, GAL3ST4, and PAGE4 shows the most selective expression in pp cells, making it the best candidate for targeting type 1 diabetes mellitus?","Which gene among EPM2A', C2orf74, SCAF11, GAL3ST4, and PAGE4 shows the most selective expression in pp cells, making it the best candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which pp cell-activated genes overlap with these targets to define a set of cell-type–specific targets. Calculate the average embedding of these overlapping targets and then compute the cosine similarity between this reference vector and each individual target’s embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CLTC', 'GP2', 'RFWD3', 'LRRC8C-DT', 'SCUBE3']",type 1 diabetes mellitus,pp cell,GP2,"Among the genes CLTC, GP2, RFWD3, LRRC8C-DT, and SCUBE3, which one demonstrates the highest cell-type specificity in pp cells and would therefore serve as the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes CLTC, GP2, RFWD3, LRRC8C-DT, and SCUBE3, which one demonstrates the highest cell-type specificity in pp cells and would therefore serve as the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the pp cell-activated gene set from PINNACLE. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFB1', 'RBM15', 'RHOBTB2', 'LINC01357', 'FRY']",type 1 diabetes mellitus,pp cell,NDUFB1,"Among the following genes—NDUFB1, RBM15, RHOBTB2, LINC01357, and FRY—which one exhibits the highest cell-type specificity in pp cells, making it the strongest candidate for targeting type 1 diabetes mellitus?","Among the following genes—NDUFB1, RBM15, RHOBTB2, LINC01357, and FRY—which one exhibits the highest cell-type specificity in pp cells, making it the strongest candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Then, identify which of those targets overlap with the pp cell-activated genes in PINNACLE. For this overlapping set, compute the average embedding as a reference and calculate the cosine similarity between each target’s embedding and this reference. Finally, determine if one gene shows a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['MORN3', 'POLR1H', 'ZNF8-DT', 'IL6ST', 'LINC02004']",type 1 diabetes mellitus,pp cell,IL6ST,"Which gene among MORN3, POLR1H, ZNF8-DT, IL6ST, and LINC02004 exhibits the highest cell-type-specific expression in pancreatic progenitor cells for therapeutic targeting of type 1 diabetes mellitus?","Which gene among MORN3, POLR1H, ZNF8-DT, IL6ST, and LINC02004 exhibits the highest cell-type-specific expression in pancreatic progenitor cells for therapeutic targeting of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the pp cell-activated genes in PINNACLE overlap with these targets to define a candidate set. Compute the average embedding for this candidate set, then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['ALX1', 'SHC2', 'FUOM', 'SMIM14', 'ARFGEF3']",type 1 diabetes mellitus,pp cell,ARFGEF3,"Which gene among ALX1, SHC2, FUOM, SMIM14, and ARFGEF3 exhibits the highest specificity for pancreatic polypeptide cells in the context of targeted therapeutic interventions for type 1 diabetes mellitus?","Which gene among ALX1, SHC2, FUOM, SMIM14, and ARFGEF3 exhibits the highest specificity for pancreatic polypeptide cells in the context of targeted therapeutic interventions for type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of pp cell-activated genes from PINNACLE to obtain a refined list of cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DPH1', 'EEF1A2', 'ALG12', 'SEZ6L2', 'DAG1']",type 1 diabetes mellitus,pp cell,DAG1,"Which gene among DPH1, EEF1A2, ALG12, SEZ6L2, and DAG1 exhibits the highest cell-type specificity in pp cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among DPH1, EEF1A2, ALG12, SEZ6L2, and DAG1 exhibits the highest cell-type specificity in pp cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the established therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which pp cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for the disease. Compute the average embedding of these overlapping targets as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LPCAT1', 'PARD3', 'CASC9', 'SMARCE1', 'PLEKHB1']",type 1 diabetes mellitus,pp cell,SMARCE1,"Which gene among LPCAT1, PARD3, CASC9, SMARCE1, and PLEKHB1 exhibits the highest cell‐type–specific expression in pp cells relevant to targeting type 1 diabetes mellitus?","Which gene among LPCAT1, PARD3, CASC9, SMARCE1, and PLEKHB1 exhibits the highest cell‐type–specific expression in pp cells relevant to targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of the pp cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['LINC00544', 'SART3', 'SMIM30', 'DNALI1', 'DBET']",type 1 diabetes mellitus,pp cell,SMIM30,"Among the candidate genes LINC00544, SART3, SMIM30, DNALI1, and DBET, which exhibits the highest cell-type specificity in pancreatic progenitor cells for potential therapeutic targeting in type 1 diabetes mellitus?","Among the candidate genes LINC00544, SART3, SMIM30, DNALI1, and DBET, which exhibits the highest cell-type specificity in pancreatic progenitor cells for potential therapeutic targeting in type 1 diabetes mellitus? Identify the cell-type–specific therapeutic targets for type 1 diabetes mellitus by first verifying targets and retrieving their embeddings from PINNACLE. Next, determine the overlap between these targets and the pp cell-activated genes defined in PINNACLE, and compute the average embedding of the overlapping set. Finally, calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FAM153CP', 'CD248', 'MEIOB', 'CHD2', 'KCNA4']",type 1 diabetes mellitus,pp cell,CHD2,"Among FAM153CP, CD248, MEIOB, CHD2, and KCNA4, which gene exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus?","Among FAM153CP, CD248, MEIOB, CHD2, and KCNA4, which gene exhibits the highest cell-type specificity in pp cells relevant to targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, find the overlap between these targets and the pp cell-activated genes in PINNACLE to obtain the cell-type–specific targets. Next, compute the average embedding for this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. If a single gene exhibits markedly higher similarity compared to the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['SSBP3', 'PPIA', 'GPR61', 'LFNG', 'TMEM72-AS1']",type 1 diabetes mellitus,pp cell,PPIA,"Which gene among SSBP3, PPIA, GPR61, LFNG, and TMEM72-AS1 exhibits the highest cell-type specificity in pp cells and is the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among SSBP3, PPIA, GPR61, LFNG, and TMEM72-AS1 exhibits the highest cell-type specificity in pp cells and is the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which pp cell-activated genes in PINNACLE overlap with these targets, thereby establishing a set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher cosine similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND1', 'ARHGEF2', 'RDH13', 'PAK1IP1', 'SLC24A5']",type 1 diabetes mellitus,pp cell,MT-ND1,"Among the genes MT-ND1, ARHGEF2, RDH13, PAK1IP1, and SLC24A5, which one exhibits the most pronounced cell-type specificity in pp cells and could thus represent the best target for type 1 diabetes mellitus?","Among the genes MT-ND1, ARHGEF2, RDH13, PAK1IP1, and SLC24A5, which one exhibits the most pronounced cell-type specificity in pp cells and could thus represent the best target for type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the pp cell-activated genes in PINNACLE to define the cell-type–specific targets for type 1 diabetes. Calculate the average embedding of this overlapping set as a reference, and then compute the cosine similarity between each individual target’s embedding and the reference. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DSG2-AS1', 'TOLLIP', 'DNAJB13', 'TRAPPC8', 'POLDIP3']",type 1 diabetes mellitus,type b pancreatic cell,TRAPPC8,"Which gene among DSG2-AS1, TOLLIP, DNAJB13, TRAPPC8, and POLDIP3 shows the highest specificity in pancreatic beta cells for potential therapeutic targeting of type 1 diabetes mellitus?","Which gene among DSG2-AS1, TOLLIP, DNAJB13, TRAPPC8, and POLDIP3 shows the highest specificity in pancreatic beta cells for potential therapeutic targeting of type 1 diabetes mellitus? Using the PINNACLE platform, identify confirmed therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and genes activated in pancreatic beta cells to obtain cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HMCN1', 'LINC01666', 'ADGRF5', 'SPRYD3', 'OCSTAMP']",type 1 diabetes mellitus,type b pancreatic cell,SPRYD3,"Which gene among HMCN1, LINC01666, ADGRF5, SPRYD3, and OCSTAMP exhibits the highest cell-type specificity in pancreatic type B cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among HMCN1, LINC01666, ADGRF5, SPRYD3, and OCSTAMP exhibits the highest cell-type specificity in pancreatic type B cells and is therefore the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the type B pancreatic cell-activated genes recorded in PINNACLE, as these represent the cell-type–specific targets for type 1 diabetes. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['RSBN1', 'TOMM70', 'MGAT4A', 'SEMA6A-AS2', 'USP27X-DT']",type 1 diabetes mellitus,type b pancreatic cell,RSBN1,"Among the genes RSBN1, TOMM70, MGAT4A, SEMA6A-AS2, and USP27X-DT, which one exhibits the highest cell-type specificity in type B pancreatic cells as a potential target for type 1 diabetes mellitus?","Among the genes RSBN1, TOMM70, MGAT4A, SEMA6A-AS2, and USP27X-DT, which one exhibits the highest cell-type specificity in type B pancreatic cells as a potential target for type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type-specific embeddings from the PINNACLE database. Next, identify which of these targets overlap with the set of type b pancreatic cell-activated genes in PINNACLE, thereby defining the cell-type-specific targets for type 1 diabetes. Compute the average embedding across these targets to create a reference vector, then calculate the cosine similarity between this reference and the embedding of each target gene. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA7', 'LLPH-DT', 'TCEA3', 'MRAP2', 'RBP7']",type 1 diabetes mellitus,type b pancreatic cell,NDUFA7,"Which gene among NDUFA7, LLPH-DT, TCEA3, MRAP2, and RBP7 exhibits the highest specificity for pancreatic β-cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among NDUFA7, LLPH-DT, TCEA3, MRAP2, and RBP7 exhibits the highest specificity for pancreatic β-cells, thereby representing the most promising candidate for targeted intervention in type 1 diabetes mellitus? Using the PINNACLE database, identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings. Determine the overlap between these targets and the type B pancreatic cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this reference embedding and the embedding for each individual target. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['LIMCH1', 'C19orf44', 'TMCC1', 'GTPBP2', 'GGTLC2']",type 1 diabetes mellitus,type b pancreatic cell,LIMCH1,"Which gene among LIMCH1, C19orf44, TMCC1, GTPBP2, and GGTLC2 exhibits the highest cell-type specificity in type b pancreatic cells with respect to type 1 diabetes mellitus?","Which gene among LIMCH1, C19orf44, TMCC1, GTPBP2, and GGTLC2 exhibits the highest cell-type specificity in type b pancreatic cells with respect to type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from PINNACLE. Then, determine the genes that overlap with the type B pancreatic cell–activated genes in PINNACLE. Compute the average embedding of these overlapping genes, and calculate the cosine similarity between this average and each individual target gene's embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MINAR2', 'INE2', 'NUCKS1', 'GCN1', 'ZBTB22']",type 1 diabetes mellitus,type b pancreatic cell,ZBTB22,"Which gene among MINAR2, INE2, NUCKS1, GCN1, and ZBTB22 exhibits the highest cell-type-specific expression in pancreatic beta cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Which gene among MINAR2, INE2, NUCKS1, GCN1, and ZBTB22 exhibits the highest cell-type-specific expression in pancreatic beta cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the type b pancreatic cell-activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for the disease. Compute the average embedding of these targets and then calculate the cosine similarity between this average and each individual target embedding. If one gene displays a substantially higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based justification for its biological relevance."
"['ZG16', 'CTRB1', 'PHLPP2', 'USP50', 'WARS2']",type 1 diabetes mellitus,type b pancreatic cell,CTRB1,"Among the genes ZG16, CTRB1, PHLPP2, USP50, and WARS2, which one exhibits the highest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus?","Among the genes ZG16, CTRB1, PHLPP2, USP50, and WARS2, which one exhibits the highest cell-type specificity in pancreatic beta cells for targeting type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes and extract their cell-type–specific embeddings from PINNACLE. Then, determine which genes activated in type b pancreatic cells overlap with these targets, as these represent the cell-type–specific targets for type 1 diabetes. Compute the average embedding of these overlapping targets and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PCDHA13', 'ZNF219', 'SLC25A27', 'PFKL', 'LRCH3']",type 1 diabetes mellitus,type b pancreatic cell,PFKL,"Among the genes PCDHA13, ZNF219, SLC25A27, PFKL, and LRCH3, which one exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus?","Among the genes PCDHA13, ZNF219, SLC25A27, PFKL, and LRCH3, which one exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping genes between these targets and the activated genes in type b pancreatic cells from the same database. Compute the average embedding for this overlapping set and calculate the cosine similarity between the reference embedding and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SMARCE1', 'NOL7', 'LINC02044', 'CASD1', 'OR3A2']",type 1 diabetes mellitus,type b pancreatic cell,SMARCE1,"Which gene among SMARCE1, NOL7, LINC02044, CASD1, and OR3A2 demonstrates the highest specificity for type B pancreatic cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among SMARCE1, NOL7, LINC02044, CASD1, and OR3A2 demonstrates the highest specificity for type B pancreatic cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the type b pancreatic cell-activated genes in PINNACLE. Calculate the average embedding of the overlapping targets and compute the cosine similarity between this average and each individual embedding. If one gene exhibits a significantly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SELENOV', 'CCDC136', 'DHX35-DT', 'CTBP2', 'TMEM72']",type 1 diabetes mellitus,type b pancreatic cell,CTBP2,"Which gene—SELENOV, CCDC136, DHX35-DT, CTBP2, or TMEM72—exhibits the highest cell-type specificity in type B pancreatic cells relevant to type 1 diabetes mellitus?","Which gene—SELENOV, CCDC136, DHX35-DT, CTBP2, or TMEM72—exhibits the highest cell-type specificity in type B pancreatic cells relevant to type 1 diabetes mellitus? Retrieve the cell-type–specific embeddings from PINNACLE for the validated therapeutic targets of type 1 diabetes mellitus. Next, identify the overlapping set between these targets and the type b pancreatic cell-activated genes in PINNACLE to define the cell-type–specific T1D targets. Calculate the average embedding of this set, then compute the cosine similarity between the average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GLB1L', 'NDUFAF3', 'AARD', 'MAX', 'RTF2']",type 1 diabetes mellitus,type b pancreatic cell,NDUFAF3,"Among the genes GLB1L, NDUFAF3, AARD, MAX, and RTF2, which one exhibits the highest specificity of expression in pancreatic beta cells, making it the most promising candidate for targeted therapeutic intervention in type 1 diabetes mellitus?","Among the genes GLB1L, NDUFAF3, AARD, MAX, and RTF2, which one exhibits the highest specificity of expression in pancreatic beta cells, making it the most promising candidate for targeted therapeutic intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Next, determine which type B pancreatic cell-activated genes within PINNACLE overlap with these targets, defining the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UNK', 'RDH13', 'WDR93', 'OR13A1', 'TRIM38']",type 1 diabetes mellitus,type b pancreatic cell,TRIM38,"Among the genes UNK, RDH13, WDR93, OR13A1, and TRIM38, which one exhibits the highest expression specificity in pancreatic beta cells, making it a promising candidate for targeting type 1 diabetes mellitus?","Among the genes UNK, RDH13, WDR93, OR13A1, and TRIM38, which one exhibits the highest expression specificity in pancreatic beta cells, making it a promising candidate for targeting type 1 diabetes mellitus? Using the PINNACLE dataset, first identify validated therapeutic targets for type 1 diabetes mellitus and extract their corresponding cell-type–specific embeddings. Next, determine the overlap between these targets and the set of type B pancreatic cell-activated genes in PINNACLE to establish a subset of cell-specific targets. Compute the average embedding for this subset and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TMEM167B-DT', 'NDUFS2', 'C6orf120', 'MAPKBP1', 'LINC00574']",type 1 diabetes mellitus,type b pancreatic cell,NDUFS2,"Among the genes TMEM167B-DT, NDUFS2, C6orf120, MAPKBP1, and LINC00574, which exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus?","Among the genes TMEM167B-DT, NDUFS2, C6orf120, MAPKBP1, and LINC00574, which exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus? Identify known therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in type b pancreatic cells overlap with these targets, thereby defining the cell-type–specific targets for type 1 diabetes mellitus. Compute the average embedding of this overlapping gene set and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ATXN7L3B', 'HCST', 'LRRC23', 'NPIPA3', 'MYO15A']",type 1 diabetes mellitus,type b pancreatic cell,ATXN7L3B,"Among the genes ATXN7L3B, HCST, LRRC23, NPIPA3, and MYO15A, which one exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus?","Among the genes ATXN7L3B, HCST, LRRC23, NPIPA3, and MYO15A, which one exhibits the highest specificity for pancreatic beta cells in the context of type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the genes activated in type b pancreatic cells in PINNACLE, considering this overlap as the cell-type–specific target set for type 1 diabetes. Compute the average embedding for this set and then calculate the cosine similarity between this average and the embedding of each individual target. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['MTMR9', 'LURAP1L', 'CLSTN1', 'CD109', 'LTBP2']",type 1 diabetes mellitus,type b pancreatic cell,LURAP1L,"Among the genes MTMR9, LURAP1L, CLSTN1, CD109, and LTBP2, which one exhibits the highest cell-type specificity in pancreatic beta cells, making it the most promising candidate for targeting type 1 diabetes mellitus?","Among the genes MTMR9, LURAP1L, CLSTN1, CD109, and LTBP2, which one exhibits the highest cell-type specificity in pancreatic beta cells, making it the most promising candidate for targeting type 1 diabetes mellitus? Identify the verified therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in type B pancreatic cells overlap with these targets, thereby defining the cell-type–specific targets for T1DM. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MICOS10', 'ACSL4', 'C6orf120', 'GPR68', 'RBM17']",type 1 diabetes mellitus,type b pancreatic cell,RBM17,"Which gene among MICOS10, ACSL4, C6orf120, GPR68, and RBM17 exhibits the highest specificity in pancreatic beta cells, indicating its potential as a target for type 1 diabetes mellitus?","Which gene among MICOS10, ACSL4, C6orf120, GPR68, and RBM17 exhibits the highest specificity in pancreatic beta cells, indicating its potential as a target for type 1 diabetes mellitus? Identify the established therapeutic targets for type 1 diabetes mellitus and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which type b pancreatic cell-activated genes in PINNACLE overlap with these targets. This overlapping set defines the cell-type–specific targets for type 1 diabetes. Calculate the average embedding for this set and compute the cosine similarity between this reference embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CAPRIN1', 'BRAP', 'FAM157C', 'DLGAP4', 'LINC01611']",type 1 diabetes mellitus,type b pancreatic cell,BRAP,"Which gene among CAPRIN1, BRAP, FAM157C, DLGAP4, and LINC01611 exhibits the highest cell-type specificity in pancreatic beta cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus?","Which gene among CAPRIN1, BRAP, FAM157C, DLGAP4, and LINC01611 exhibits the highest cell-type specificity in pancreatic beta cells, making it the most promising candidate for targeted intervention in type 1 diabetes mellitus? Identify validated therapeutic targets for type 1 diabetes mellitus and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which type B pancreatic cell-activated genes overlap with these targets to establish the cell-type–specific target set. Compute the average embedding for this set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits significantly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['TMEM178B', 'ACAP1', 'HSPBP1', 'COX8A', 'LINC01785']",type 1 diabetes mellitus,type b pancreatic cell,ACAP1,"Which gene among TMEM178B, ACAP1, HSPBP1, COX8A, and LINC01785 exhibits the greatest cell-type specificity in type B pancreatic cells for potential targeting in type 1 diabetes mellitus?","Which gene among TMEM178B, ACAP1, HSPBP1, COX8A, and LINC01785 exhibits the greatest cell-type specificity in type B pancreatic cells for potential targeting in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and extract their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the set of type b pancreatic cell-activated genes within PINNACLE to define the cell-type–specific targets for type 1 diabetes. Compute the average embedding of these targets to create a reference profile, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CATSPER4', 'ERVE-1', 'KIAA0319L', 'TAFA3', 'GZF1']",type 1 diabetes mellitus,type b pancreatic cell,KIAA0319L,"Among the genes CATSPER4, ERVE-1, KIAA0319L, TAFA3, and GZF1, which is most specifically expressed in type B pancreatic cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes CATSPER4, ERVE-1, KIAA0319L, TAFA3, and GZF1, which is most specifically expressed in type B pancreatic cells, making it the best candidate for targeted intervention in type 1 diabetes mellitus? For type 1 diabetes mellitus, how can we identify verified therapeutic targets and obtain their cell-type–specific embeddings from PINNACLE? Subsequently, how do we determine which of the type b pancreatic cell-activated genes from PINNACLE overlap with these targets, compute the average embedding for this overlapping set, and calculate the cosine similarity between this average and each individual target embedding? If one gene exhibits a significantly higher similarity than the others, please identify it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LNCARSR', 'SLC35G4', 'EEF1AKMT4', 'NDUFB8', 'PHYHIP']",type 1 diabetes mellitus,type b pancreatic cell,NDUFB8,"Among the genes LNCARSR, SLC35G4, EEF1AKMT4, NDUFB8, and PHYHIP, which one exhibits the highest specificity for pancreatic beta cells and would therefore be the best candidate for targeted intervention in type 1 diabetes mellitus?","Among the genes LNCARSR, SLC35G4, EEF1AKMT4, NDUFB8, and PHYHIP, which one exhibits the highest specificity for pancreatic beta cells and would therefore be the best candidate for targeted intervention in type 1 diabetes mellitus? Identify the validated therapeutic targets for type 1 diabetes mellitus and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the type b pancreatic cell-activated genes from PINNACLE. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
